###begin article-title 0
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes in the population of mainland China
###end article-title 0
###begin title 1
Aims/hypothesis
###end title 1
###begin p 2
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
Two recent genome-wide association studies have identified several novel type 2 diabetes susceptibility variants in intron 15 of the KCNQ1 gene. We aimed to evaluate the effects of the variants in KCNQ1 on type 2 diabetes and metabolic traits in the population of mainland China.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
Three candidate single nucleotide polymorphisms were genotyped in 1,912 individuals with type 2 diabetes and 2,041 normal controls using the ligase detection reaction method.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 268 269 268 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 280 282 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 339 341 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 504 506 504 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 679 681 679 681 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
We confirmed the association of KCNQ1 with type 2 diabetes in the population of mainland China. Allele frequency ORs of the three single nucleotide polymorphisms (SNPs) were: rs2237892 (OR 1.19, 95% CI 1.08-1.31, p = 3.0 x 10-4); rs2237895 (OR 1.20, 95% CI 1.09-1.32, p = 1.9 x 10-4); and rs2237897 (OR 1.24, 95% CI 1.13-1.36, p = 3.9 x 10-5). We also found a significant difference in the distribution of the global haplotypes between the type 2 diabetes group and the normal control group (p = 2.6 x 10-5). In addition, in the control group SNP rs2237892 was marginally associated with increasing fasting plasma glucose and SNPs rs2237892 and rs2237897 were associated with HbA1c. Furthermore, for all three variants, homozygous carriers of the diabetes-associated allele had significantly decreased BMI and waist circumferences.
###end p 6
###begin title 7
Conclusions/interpretation
###end title 7
###begin p 8
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
Our investigation confirmed the effects of KCNQ1 variants on type 2 diabetes risk in the Chinese population.
###end p 8
###begin title 9
Electronic supplementary material
###end title 9
###begin p 10
The online version of this article (doi:10.1007/s00125-009-1375-y) contains supplementary material, which is available to authorised users.
###end p 10
###begin title 11
Keywords
###end title 11
###begin title 12
Introduction
###end title 12
###begin p 13
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 222 228 <span type="species:ncbi:9606">people</span>
Type 2 diabetes is a major health problem affecting more than 200 million individuals worldwide. Its prevalence is increasing in many countries, especially in the developing countries [1]. For example, the total number of people with diabetes in China is estimated to increase from 20.8 million in 2000 to 42.3 million by 2030. Type 2 diabetes is characterised by the presence of insulin resistance and pancreatic beta cell dysfunction, resulting from the interaction of genetic and environmental factors.
###end p 13
###begin p 14
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 169 175 169 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 179 180 179 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 587 594 587 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 602 608 602 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 610 624 610 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A, CDKN2B</italic>
###xml 626 633 626 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 638 641 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FTO</italic>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 742 744 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
So far a few genes, identified through linkage scans or the candidate gene approach, have been confirmed as being associated with type 2 diabetes e.g. PPARG, KCNJ11 and TCF7L2 [2-4]. Recently, the use of genome-wide association scans as an investigative tool has led to a qualitative leap in identifying diabetes-related genes. Genome-wide association studies conducted in large-scale case-control samples by several independent European and American research groups have identified several novel genes and loci with modest effects on the risk of type 2 diabetes (OR 1.14-1.20), such as SLC30A8, HHEX, CDKAL1, CDKN2A, CDKN2B, IGF2BP2 and FTO [5-10]. These studies have been replicated and results confirmed in several other ethnic groups [11-17].
###end p 14
###begin p 15
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 706 711 706 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
The two most recent genome-wide association studies, in the Japanese population, have identified the association of a novel gene (KCNQ1) with the risk of type 2 diabetes; a similar association was also detected in some Asian and European populations in these studies [18, 19]. Recently, Tan et al. also found variants in KCNQ1 to be associated with type 2 diabetes, fasting glucose and beta cell function in 3,734 individuals belonging to three ethnic groups living in Singapore [20]. It is well known that there are significant differences in the frequencies of some genetic variations among different ethnic groups and geographic regions. Therefore, we decided to investigate further the contribution of KCNQ1 to the aetiology of type 2 diabetes and to determine whether variants of the KCNQ1 gene were associated with the susceptibility to type 2 diabetes and diabetes-related metabolic traits in the population of mainland China. We also used haplotype analysis and the best-fitting model test in our investigation.
###end p 15
###begin title 16
Methods
###end title 16
###begin p 17
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Participants</bold>
###xml 362 364 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 887 889 883 885 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1129 1130 1123 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1133 1140 1127 1134 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1140 1190 1134 1184 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">Clinical characteristics of the study participants</p>
###xml 1140 1190 1134 1184 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">Clinical characteristics of the study participants</p></caption>
###xml 1190 1204 1184 1198 <th xmlns:xlink="http://www.w3.org/1999/xlink">Characteristic</th>
###xml 1204 1219 1198 1213 <th xmlns:xlink="http://www.w3.org/1999/xlink">Type 2 diabetes</th>
###xml 1219 1227 1213 1221 <th xmlns:xlink="http://www.w3.org/1999/xlink">Controls</th>
###xml 1190 1227 1184 1221 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Characteristic</th><th>Type 2 diabetes</th><th>Controls</th></tr>
###xml 1190 1227 1184 1221 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>Characteristic</th><th>Type 2 diabetes</th><th>Controls</th></tr></thead>
###xml 1227 1233 1221 1227 <td xmlns:xlink="http://www.w3.org/1999/xlink">Number</td>
###xml 1233 1238 1227 1232 <td xmlns:xlink="http://www.w3.org/1999/xlink">1,912</td>
###xml 1238 1243 1232 1237 <td xmlns:xlink="http://www.w3.org/1999/xlink">2,041</td>
###xml 1227 1243 1221 1237 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Number</td><td>1,912</td><td>2,041</td></tr>
###xml 1254 1255 1248 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1256 1257 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1243 1258 1237 1252 <td xmlns:xlink="http://www.w3.org/1999/xlink">Men/women (<italic>n</italic>/<italic>n</italic>)</td>
###xml 1258 1267 1252 1261 <td xmlns:xlink="http://www.w3.org/1999/xlink">785/1,127</td>
###xml 1267 1276 1261 1270 <td xmlns:xlink="http://www.w3.org/1999/xlink">635/1,406</td>
###xml 1243 1276 1237 1270 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Men/women (<italic>n</italic>/<italic>n</italic>)</td><td>785/1,127</td><td>635/1,406</td></tr>
###xml 1276 1287 1270 1281 <td xmlns:xlink="http://www.w3.org/1999/xlink">Age (years)</td>
###xml 1287 1299 1281 1291 <td xmlns:xlink="http://www.w3.org/1999/xlink">63.9&#8201;&#177;&#8201;9.5</td>
###xml 1299 1311 1291 1301 <td xmlns:xlink="http://www.w3.org/1999/xlink">58.1&#8201;&#177;&#8201;9.4</td>
###xml 1276 1311 1270 1301 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Age (years)</td><td>63.9&#8201;&#177;&#8201;9.5</td><td>58.1&#8201;&#177;&#8201;9.4</td></tr>
###xml 1320 1321 1310 1311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1311 1322 1301 1312 <td xmlns:xlink="http://www.w3.org/1999/xlink">BMI (kg/m<sup>2</sup>)</td>
###xml 1322 1335 1312 1323 <td xmlns:xlink="http://www.w3.org/1999/xlink">25.3&#8201;&#177;&#8201;3.48</td>
###xml 1335 1348 1323 1334 <td xmlns:xlink="http://www.w3.org/1999/xlink">24.5&#8201;&#177;&#8201;3.24</td>
###xml 1311 1348 1301 1334 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>BMI (kg/m<sup>2</sup>)</td><td>25.3&#8201;&#177;&#8201;3.48</td><td>24.5&#8201;&#177;&#8201;3.24</td></tr>
###xml 1348 1366 1334 1352 <td xmlns:xlink="http://www.w3.org/1999/xlink">Waist to hip ratio</td>
###xml 1366 1379 1352 1363 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.89&#8201;&#177;&#8201;0.06</td>
###xml 1379 1392 1363 1374 <td xmlns:xlink="http://www.w3.org/1999/xlink">0.86&#8201;&#177;&#8201;0.06</td>
###xml 1348 1392 1334 1374 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Waist to hip ratio</td><td>0.89&#8201;&#177;&#8201;0.06</td><td>0.86&#8201;&#177;&#8201;0.06</td></tr>
###xml 1392 1422 1374 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fasting blood glucose (mmol/l)</td>
###xml 1422 1438 1404 1420 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.42 (6.08&#8211;9.49)</td>
###xml 1438 1454 1420 1436 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.89 (4.51&#8211;5.25)</td>
###xml 1392 1454 1374 1436 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fasting blood glucose (mmol/l)</td><td>7.42 (6.08&#8211;9.49)</td><td>4.89 (4.51&#8211;5.25)</td></tr>
###xml 1454 1478 1436 1460 <td xmlns:xlink="http://www.w3.org/1999/xlink">Triacylglycerol (mmol/l)</td>
###xml 1478 1494 1460 1476 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.51 (1.07&#8211;2.19)</td>
###xml 1494 1510 1476 1492 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.34 (0.94&#8211;1.91)</td>
###xml 1454 1510 1436 1492 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Triacylglycerol (mmol/l)</td><td>1.51 (1.07&#8211;2.19)</td><td>1.34 (0.94&#8211;1.91)</td></tr>
###xml 1510 1536 1492 1518 <td xmlns:xlink="http://www.w3.org/1999/xlink">Total cholesterol (mmol/l)</td>
###xml 1536 1552 1518 1534 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.40 (3.82&#8211;5.03)</td>
###xml 1552 1567 1534 1549 <td xmlns:xlink="http://www.w3.org/1999/xlink">4.44 (3.9&#8211;5.02)</td>
###xml 1510 1567 1492 1549 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Total cholesterol (mmol/l)</td><td>4.40 (3.82&#8211;5.03)</td><td>4.44 (3.9&#8211;5.02)</td></tr>
###xml 1567 1591 1549 1573 <td xmlns:xlink="http://www.w3.org/1999/xlink">HDL-cholesterol (mmol/l)</td>
###xml 1591 1607 1573 1589 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.14 (0.96&#8211;1.35)</td>
###xml 1607 1623 1589 1605 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.22 (1.03&#8211;1.46)</td>
###xml 1567 1623 1549 1605 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HDL-cholesterol (mmol/l)</td><td>1.14 (0.96&#8211;1.35)</td><td>1.22 (1.03&#8211;1.46)</td></tr>
###xml 1623 1647 1605 1629 <td xmlns:xlink="http://www.w3.org/1999/xlink">LDL-cholesterol (mmol/l)</td>
###xml 1647 1661 1629 1643 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.7 (2.24&#8211;3.2)</td>
###xml 1661 1677 1643 1659 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.74 (2.33&#8211;3.26)</td>
###xml 1623 1677 1605 1659 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>LDL-cholesterol (mmol/l)</td><td>2.7 (2.24&#8211;3.2)</td><td>2.74 (2.33&#8211;3.26)</td></tr>
###xml 1677 1707 1659 1689 <td xmlns:xlink="http://www.w3.org/1999/xlink">Systolic blood pressure (mmHg)</td>
###xml 1707 1720 1689 1702 <td xmlns:xlink="http://www.w3.org/1999/xlink">140 (127&#8211;151)</td>
###xml 1720 1733 1702 1715 <td xmlns:xlink="http://www.w3.org/1999/xlink">130 (120&#8211;141)</td>
###xml 1677 1733 1659 1715 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Systolic blood pressure (mmHg)</td><td>140 (127&#8211;151)</td><td>130 (120&#8211;141)</td></tr>
###xml 1733 1764 1715 1746 <td xmlns:xlink="http://www.w3.org/1999/xlink">Diastolic blood pressure (mmHg)</td>
###xml 1764 1774 1746 1756 <td xmlns:xlink="http://www.w3.org/1999/xlink">80 (76&#8211;90)</td>
###xml 1774 1784 1756 1766 <td xmlns:xlink="http://www.w3.org/1999/xlink">80 (74&#8211;89)</td>
###xml 1733 1784 1715 1766 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Diastolic blood pressure (mmHg)</td><td>80 (76&#8211;90)</td><td>80 (74&#8211;89)</td></tr>
###xml 1787 1789 1769 1771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1784 1793 1766 1775 <td xmlns:xlink="http://www.w3.org/1999/xlink">HbA<sub>1c</sub> (%)</td>
###xml 1793 1809 1775 1791 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.11 (6.38&#8211;8.31)</td>
###xml 1809 1825 1791 1807 <td xmlns:xlink="http://www.w3.org/1999/xlink">5.80 (5.46&#8211;6.11)</td>
###xml 1784 1825 1766 1807 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HbA<sub>1c</sub> (%)</td><td>7.11 (6.38&#8211;8.31)</td><td>5.80 (5.46&#8211;6.11)</td></tr>
###xml 1825 1836 1807 1818 <td xmlns:xlink="http://www.w3.org/1999/xlink">Obesity (%)</td>
###xml 1836 1840 1818 1822 <td xmlns:xlink="http://www.w3.org/1999/xlink">20.7</td>
###xml 1840 1844 1822 1826 <td xmlns:xlink="http://www.w3.org/1999/xlink">14.1</td>
###xml 1825 1844 1807 1826 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Obesity (%)</td><td>20.7</td><td>14.1</td></tr>
###xml 1227 1844 1221 1826 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>Number</td><td>1,912</td><td>2,041</td></tr><tr><td>Men/women (<italic>n</italic>/<italic>n</italic>)</td><td>785/1,127</td><td>635/1,406</td></tr><tr><td>Age (years)</td><td>63.9&#8201;&#177;&#8201;9.5</td><td>58.1&#8201;&#177;&#8201;9.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.3&#8201;&#177;&#8201;3.48</td><td>24.5&#8201;&#177;&#8201;3.24</td></tr><tr><td>Waist to hip ratio</td><td>0.89&#8201;&#177;&#8201;0.06</td><td>0.86&#8201;&#177;&#8201;0.06</td></tr><tr><td>Fasting blood glucose (mmol/l)</td><td>7.42 (6.08&#8211;9.49)</td><td>4.89 (4.51&#8211;5.25)</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td>1.51 (1.07&#8211;2.19)</td><td>1.34 (0.94&#8211;1.91)</td></tr><tr><td>Total cholesterol (mmol/l)</td><td>4.40 (3.82&#8211;5.03)</td><td>4.44 (3.9&#8211;5.02)</td></tr><tr><td>HDL-cholesterol (mmol/l)</td><td>1.14 (0.96&#8211;1.35)</td><td>1.22 (1.03&#8211;1.46)</td></tr><tr><td>LDL-cholesterol (mmol/l)</td><td>2.7 (2.24&#8211;3.2)</td><td>2.74 (2.33&#8211;3.26)</td></tr><tr><td>Systolic blood pressure (mmHg)</td><td>140 (127&#8211;151)</td><td>130 (120&#8211;141)</td></tr><tr><td>Diastolic blood pressure (mmHg)</td><td>80 (76&#8211;90)</td><td>80 (74&#8211;89)</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td>7.11 (6.38&#8211;8.31)</td><td>5.80 (5.46&#8211;6.11)</td></tr><tr><td>Obesity (%)</td><td>20.7</td><td>14.1</td></tr></tbody>
###xml 1190 1844 1184 1826 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Type 2 diabetes</th><th>Controls</th></tr></thead><tbody><tr><td>Number</td><td>1,912</td><td>2,041</td></tr><tr><td>Men/women (<italic>n</italic>/<italic>n</italic>)</td><td>785/1,127</td><td>635/1,406</td></tr><tr><td>Age (years)</td><td>63.9&#8201;&#177;&#8201;9.5</td><td>58.1&#8201;&#177;&#8201;9.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.3&#8201;&#177;&#8201;3.48</td><td>24.5&#8201;&#177;&#8201;3.24</td></tr><tr><td>Waist to hip ratio</td><td>0.89&#8201;&#177;&#8201;0.06</td><td>0.86&#8201;&#177;&#8201;0.06</td></tr><tr><td>Fasting blood glucose (mmol/l)</td><td>7.42 (6.08&#8211;9.49)</td><td>4.89 (4.51&#8211;5.25)</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td>1.51 (1.07&#8211;2.19)</td><td>1.34 (0.94&#8211;1.91)</td></tr><tr><td>Total cholesterol (mmol/l)</td><td>4.40 (3.82&#8211;5.03)</td><td>4.44 (3.9&#8211;5.02)</td></tr><tr><td>HDL-cholesterol (mmol/l)</td><td>1.14 (0.96&#8211;1.35)</td><td>1.22 (1.03&#8211;1.46)</td></tr><tr><td>LDL-cholesterol (mmol/l)</td><td>2.7 (2.24&#8211;3.2)</td><td>2.74 (2.33&#8211;3.26)</td></tr><tr><td>Systolic blood pressure (mmHg)</td><td>140 (127&#8211;151)</td><td>130 (120&#8211;141)</td></tr><tr><td>Diastolic blood pressure (mmHg)</td><td>80 (76&#8211;90)</td><td>80 (74&#8211;89)</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td>7.11 (6.38&#8211;8.31)</td><td>5.80 (5.46&#8211;6.11)</td></tr><tr><td>Obesity (%)</td><td>20.7</td><td>14.1</td></tr></tbody></table>
###xml 1844 1891 1826 1871 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19">Data are medians (25&#8211;75% range) or means&#8201;&#177;&#8201;SD</p>
###xml 1844 1891 1826 1871 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19">Data are medians (25&#8211;75% range) or means&#8201;&#177;&#8201;SD</p></table-wrap-foot>
###xml 1133 1891 1127 1871 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="18">Clinical characteristics of the study participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Type 2 diabetes</th><th>Controls</th></tr></thead><tbody><tr><td>Number</td><td>1,912</td><td>2,041</td></tr><tr><td>Men/women (<italic>n</italic>/<italic>n</italic>)</td><td>785/1,127</td><td>635/1,406</td></tr><tr><td>Age (years)</td><td>63.9&#8201;&#177;&#8201;9.5</td><td>58.1&#8201;&#177;&#8201;9.4</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>25.3&#8201;&#177;&#8201;3.48</td><td>24.5&#8201;&#177;&#8201;3.24</td></tr><tr><td>Waist to hip ratio</td><td>0.89&#8201;&#177;&#8201;0.06</td><td>0.86&#8201;&#177;&#8201;0.06</td></tr><tr><td>Fasting blood glucose (mmol/l)</td><td>7.42 (6.08&#8211;9.49)</td><td>4.89 (4.51&#8211;5.25)</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td>1.51 (1.07&#8211;2.19)</td><td>1.34 (0.94&#8211;1.91)</td></tr><tr><td>Total cholesterol (mmol/l)</td><td>4.40 (3.82&#8211;5.03)</td><td>4.44 (3.9&#8211;5.02)</td></tr><tr><td>HDL-cholesterol (mmol/l)</td><td>1.14 (0.96&#8211;1.35)</td><td>1.22 (1.03&#8211;1.46)</td></tr><tr><td>LDL-cholesterol (mmol/l)</td><td>2.7 (2.24&#8211;3.2)</td><td>2.74 (2.33&#8211;3.26)</td></tr><tr><td>Systolic blood pressure (mmHg)</td><td>140 (127&#8211;151)</td><td>130 (120&#8211;141)</td></tr><tr><td>Diastolic blood pressure (mmHg)</td><td>80 (76&#8211;90)</td><td>80 (74&#8211;89)</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td>7.11 (6.38&#8211;8.31)</td><td>5.80 (5.46&#8211;6.11)</td></tr><tr><td>Obesity (%)</td><td>20.7</td><td>14.1</td></tr></tbody></table><table-wrap-foot><p textid="19">Data are medians (25&#8211;75% range) or means&#8201;&#177;&#8201;SD</p></table-wrap-foot></table-wrap>
###xml 0 12 <span type="species:ncbi:9606">Participants</span>
###xml 46 58 <span type="species:ncbi:9606">participants</span>
###xml 161 164 <span type="species:ncbi:9606">men</span>
###xml 172 177 <span type="species:ncbi:9606">women</span>
###xml 238 241 <span type="species:ncbi:9606">men</span>
###xml 249 254 <span type="species:ncbi:9606">women</span>
###xml 376 388 <span type="species:ncbi:9606">participants</span>
###xml 722 734 <span type="species:ncbi:9606">Participants</span>
###xml 1247 1252 <span type="species:ncbi:9606">women</span>
Participants In this study, 3,953 Chinese Han participants were recruited from Shanghai, China; these comprised 1,912 unrelated type 2 diabetic individuals (785 men, 1,127 women; age 63.9 +/- 9.5 years) and 2,041 control individuals (635 men, 1,406 women; age 58.1 +/- 9.4 years). The study population overlapped completely with that used in our previous study [16]. Diabetic participants were defined in accordance with WHO criteria. Controls with a fasting plasma glucose concentration <6.1 mmol/l were enrolled from the same geographical region. A standard informed consent procedure was included in the protocol, and was reviewed and approved by the Ethics Committee of the Shanghai Institute for Biological Sciences. Participants gave their consent after the nature of study had been fully explained.Blood samples were drawn for biochemical measurements (fasting plasma glucose, HbA1c, total cholesterol, triacylglycerol, HDL-cholesterol and LDL-cholesterol). Height, weight, waist and hip circumferences, and blood pressure were measured in all individuals. Data are showed as medians (25-75% range) or means +/- SD (Table 1). Table 1Clinical characteristics of the study participantsCharacteristicType 2 diabetesControlsNumber1,9122,041Men/women (n/n)785/1,127635/1,406Age (years)63.9 +/- 9.558.1 +/- 9.4BMI (kg/m2)25.3 +/- 3.4824.5 +/- 3.24Waist to hip ratio0.89 +/- 0.060.86 +/- 0.06Fasting blood glucose (mmol/l)7.42 (6.08-9.49)4.89 (4.51-5.25)Triacylglycerol (mmol/l)1.51 (1.07-2.19)1.34 (0.94-1.91)Total cholesterol (mmol/l)4.40 (3.82-5.03)4.44 (3.9-5.02)HDL-cholesterol (mmol/l)1.14 (0.96-1.35)1.22 (1.03-1.46)LDL-cholesterol (mmol/l)2.7 (2.24-3.2)2.74 (2.33-3.26)Systolic blood pressure (mmHg)140 (127-151)130 (120-141)Diastolic blood pressure (mmHg)80 (76-90)80 (74-89)HbA1c (%)7.11 (6.38-8.31)5.80 (5.46-6.11)Obesity (%)20.714.1Data are medians (25-75% range) or means +/- SD
###end p 17
###begin p 18
###xml 38 50 <span type="species:ncbi:9606">participants</span>
Clinical characteristics of the study participants
###end p 18
###begin p 19
Data are medians (25-75% range) or means +/- SD
###end p 19
###begin p 20
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Single nucleotide polymorphism selection</bold>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 407 409 407 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 414 415 414 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 415 416 415 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 481 482 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
Single nucleotide polymorphism selection For the KCNQ1 gene, five single nucleotide polymorphisms (SNPs) (rs2237892, rs2237895, rs2237897, rs2074196 and rs2283228) were identified as having the most significant association with type 2 diabetes based on previous studies [18-20]. After considering the linkage disequilibrium (LD) structure based on HapMap Han Chinese and the pairwise linkage disequilibrium D' and r2 values, we used rs2237892 to represent rs2074196 and rs2283228 (r2 = 0.73 and 0.95, respectively) and thus selected three representative variants (rs2237892, rs2237895 and rs2237897) to be genotyped in our study.
###end p 20
###begin p 21
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genotyping</bold>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
Genotyping High molecular weight genomic DNA was prepared from venous blood using the QuickGene 610L Automatic DNA/RNA Extraction System (Fujifilm, Tokyo, Japan). All the genotyping experiments were done using ligase detection reactions [21]. All genotyping success rates were above 98% and all mismatch rates were below 1% in 1641 duplicate samples.
###end p 21
###begin p 22
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Statistical analysis</bold>
###xml 37 39 37 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 223 225 223 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 230 231 230 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1027 1028 1027 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1027 1028 1027 1028 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1103 1104 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1104 1105 1104 1105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">c</sub>
###xml 1160 1161 1160 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1160 1161 1160 1161 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i</italic></sub>
###xml 1174 1178 1174 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1181 1182 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 1208 1209 1205 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 1243 1247 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;</italic>
###xml 1297 1298 1291 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 1304 1305 1298 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 1443 1448 1437 1442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 1656 1657 1650 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1656 1657 1650 1651 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
###xml 1958 1959 1952 1953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1958 1959 1952 1953 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
###xml 2075 2076 2069 2070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Statistical analysis We used SHEsis [22] to perform the Hardy-Weinberg equilibrium test, to compare the differences of allele, genotype and haplotype frequencies between cases and controls and to calculate LD coefficients (D' and r2) in the control group.To establish the closest best-fit model for each SNP, we carried out the logistic regression analysis by comparing additive, dominant and recessive models with age, sex and loge BMI as covariants, and the model that had the lowest Akaike's information criterion value was considered to be the best-fitting model for the respective SNP. In the additive model, homozygotes for the risk allele (1/1), heterozygotes (1/0) and homozygotes for the non-risk allele (0/0) were coded to an ordered categorical variable for the genotype (2, 1 and 0, respectively). The dominant model was defined as 1/1 + 1/0 vs 0/0 and the recessive model as 1/1 vs 1/0 + 0/0. The association of the SNPs with type 2 diabetes was assessed by logistic regression after adjusting for sex, age and loge BMI. The population attributable risk (PAR) [23] was calculated as: where nc is the number if individuals in each case group and ORi is equal to beta x Y (the estimated OR of the ith individual in each case group [beta is the regression coefficient vector in terms of Y, and Y is the term for the respective SNP in the logistic regression model]). In addition, to analyse the independent effect of each SNP in the KCNQ1 gene, we carried out a conditional analysis by including the most significant SNP in the region and the SNP being tested, coded according to the most appropriate genetic model, combined with age, sex and loge BMI as covariates, in a logistic regression analysis.For quantitative traits in relation to genotypes, a general linear statistical method was used, applying additive, dominant and recessive models while adjusting for the effect of age and sex (BMI, waist and waist to hip ratio), or age, sex and loge BMI (all other traits). The statistical analyses were performed using the SPSS (SPSS, Chicago, IL, USA) program. A p value <0.05 was considered significant.
###end p 22
###begin title 23
Results
###end title 23
###begin p 24
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 255 257 255 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM1">1</xref>
###xml 699 700 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 699 700 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
###xml 809 810 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 821 823 821 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 876 877 876 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 888 890 888 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 943 944 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 955 957 955 957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 978 979 978 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 982 989 982 989 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 1022 1027 1022 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 989 1101 989 1101 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Association of candidate SNPs in <italic>KCNQ1</italic> with type 2 diabetes in participants with type 2 diabetes and in controls</p>
###xml 989 1101 989 1101 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25">Association of candidate SNPs in <italic>KCNQ1</italic> with type 2 diabetes in participants with type 2 diabetes and in controls</p></caption>
###xml 1101 1104 1101 1104 <th xmlns:xlink="http://www.w3.org/1999/xlink">SNP</th>
###xml 1104 1109 1104 1109 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Group</th>
###xml 1109 1120 1109 1120 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Allele data</th>
###xml 1120 1145 1120 1145 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Genotype distribution (%)</th>
###xml 1145 1159 1145 1159 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="2">Additive model</th>
###xml 1101 1159 1101 1159 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>SNP</th><th rowspan="2">Group</th><th colspan="3">Allele data</th><th colspan="3">Genotype distribution (%)</th><th colspan="2">Additive model</th></tr>
###xml 1159 1165 1159 1165 <th xmlns:xlink="http://www.w3.org/1999/xlink">Allele</th>
###xml 1174 1175 1174 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1165 1179 1165 1179 <th xmlns:xlink="http://www.w3.org/1999/xlink">Frequency<sup>a</sup> (%)</th>
###xml 1179 1190 1179 1190 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 1190 1191 1190 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1190 1197 1190 1197 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic> value</th>
###xml 1197 1200 1197 1200 <th xmlns:xlink="http://www.w3.org/1999/xlink">C/C</th>
###xml 1200 1203 1200 1203 <th xmlns:xlink="http://www.w3.org/1999/xlink">C/R</th>
###xml 1203 1206 1203 1206 <th xmlns:xlink="http://www.w3.org/1999/xlink">R/R</th>
###xml 1206 1217 1206 1217 <th xmlns:xlink="http://www.w3.org/1999/xlink">OR (95% CI)</th>
###xml 1217 1218 1217 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1224 1225 1224 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1217 1225 1217 1225 <th xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic> value<sup>b</sup></th>
###xml 1159 1225 1159 1225 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Allele</th><th>Frequency<sup>a</sup> (%)</th><th>OR (95% CI)</th><th><italic>p</italic> value</th><th>C/C</th><th>C/R</th><th>R/R</th><th>OR (95% CI)</th><th><italic>p</italic> value<sup>b</sup></th></tr>
###xml 1101 1225 1101 1225 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>SNP</th><th rowspan="2">Group</th><th colspan="3">Allele data</th><th colspan="3">Genotype distribution (%)</th><th colspan="2">Additive model</th></tr><tr><th>Allele</th><th>Frequency<sup>a</sup> (%)</th><th>OR (95% CI)</th><th><italic>p</italic> value</th><th>C/C</th><th>C/R</th><th>R/R</th><th>OR (95% CI)</th><th><italic>p</italic> value<sup>b</sup></th></tr></thead>
###xml 1236 1237 1236 1237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1240 1241 1240 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1225 1241 1225 1241 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2237892 T<sup>c</sup>, C<sup>d</sup></td>
###xml 1241 1245 1241 1245 <td xmlns:xlink="http://www.w3.org/1999/xlink">Case</td>
###xml 1245 1249 1245 1249 <td xmlns:xlink="http://www.w3.org/1999/xlink">69.6</td>
###xml 1249 1265 1249 1265 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.19 (1.08&#8211;1.31)</td>
###xml 1273 1275 1273 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1265 1275 1265 1275 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.0&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td>
###xml 1275 1284 1275 1284 <td xmlns:xlink="http://www.w3.org/1999/xlink">165 (8.8)</td>
###xml 1284 1294 1284 1294 <td xmlns:xlink="http://www.w3.org/1999/xlink">813 (43.2)</td>
###xml 1294 1304 1294 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink">902 (48.0)</td>
###xml 1320 1321 1320 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 1304 1321 1304 1321 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.23 (1.11&#8211;1.36)<sup>e</sup></td>
###xml 1329 1331 1329 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1321 1331 1321 1331 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.1&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td>
###xml 1225 1331 1225 1331 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2237892 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>69.6</td><td>1.19 (1.08&#8211;1.31)</td><td>3.0&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>165 (8.8)</td><td>813 (43.2)</td><td>902 (48.0)</td><td>1.23 (1.11&#8211;1.36)<sup>e</sup></td><td>1.1&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td></tr>
###xml 1331 1331 1331 1331 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1331 1338 1331 1338 <td xmlns:xlink="http://www.w3.org/1999/xlink">Control</td>
###xml 1338 1342 1338 1342 <td xmlns:xlink="http://www.w3.org/1999/xlink">65.8</td>
###xml 1342 1342 1342 1342 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1342 1342 1342 1342 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1342 1352 1342 1352 <td xmlns:xlink="http://www.w3.org/1999/xlink">224 (11.2)</td>
###xml 1352 1362 1352 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink">919 (46.0)</td>
###xml 1362 1372 1362 1372 <td xmlns:xlink="http://www.w3.org/1999/xlink">853 (42.7)</td>
###xml 1372 1372 1372 1372 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1372 1372 1372 1372 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1331 1372 1331 1372 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td/><td>Control</td><td>65.8</td><td/><td/><td>224 (11.2)</td><td>919 (46.0)</td><td>853 (42.7)</td><td/><td/></tr>
###xml 1383 1386 1383 1386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c,d</sup>
###xml 1372 1389 1372 1389 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2237895 C<sup>c,d</sup>, A</td>
###xml 1389 1393 1389 1393 <td xmlns:xlink="http://www.w3.org/1999/xlink">Case</td>
###xml 1393 1397 1393 1397 <td xmlns:xlink="http://www.w3.org/1999/xlink">34.6</td>
###xml 1397 1413 1397 1413 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.20 (1.09&#8211;1.32)</td>
###xml 1421 1423 1421 1423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1413 1423 1413 1423 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.9&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td>
###xml 1423 1433 1423 1433 <td xmlns:xlink="http://www.w3.org/1999/xlink">209 (11.1)</td>
###xml 1433 1443 1433 1443 <td xmlns:xlink="http://www.w3.org/1999/xlink">886 (47.0)</td>
###xml 1443 1453 1443 1453 <td xmlns:xlink="http://www.w3.org/1999/xlink">790 (41.9)</td>
###xml 1469 1470 1469 1470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f</sup>
###xml 1453 1470 1453 1470 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.23 (1.11&#8211;1.37)<sup>f</sup></td>
###xml 1478 1480 1478 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 1470 1480 1470 1480 <td xmlns:xlink="http://www.w3.org/1999/xlink">7.8&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td>
###xml 1372 1480 1372 1480 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2237895 C<sup>c,d</sup>, A</td><td>Case</td><td>34.6</td><td>1.20 (1.09&#8211;1.32)</td><td>1.9&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>209 (11.1)</td><td>886 (47.0)</td><td>790 (41.9)</td><td>1.23 (1.11&#8211;1.37)<sup>f</sup></td><td>7.8&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td></tr>
###xml 1480 1480 1480 1480 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1480 1487 1480 1487 <td xmlns:xlink="http://www.w3.org/1999/xlink">Control</td>
###xml 1487 1491 1487 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink">30.6</td>
###xml 1491 1491 1491 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1491 1491 1491 1491 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1491 1500 1491 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink">169 (8.5)</td>
###xml 1500 1510 1500 1510 <td xmlns:xlink="http://www.w3.org/1999/xlink">883 (44.3)</td>
###xml 1510 1520 1510 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink">942 (47.2)</td>
###xml 1520 1520 1520 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1520 1520 1520 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1480 1520 1480 1520 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td/><td>Control</td><td>30.6</td><td/><td/><td>169 (8.5)</td><td>883 (44.3)</td><td>942 (47.2)</td><td/><td/></tr>
###xml 1531 1532 1531 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1535 1536 1535 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1520 1536 1520 1536 <td xmlns:xlink="http://www.w3.org/1999/xlink">rs2237897 T<sup>c</sup>, C<sup>d</sup></td>
###xml 1536 1540 1536 1540 <td xmlns:xlink="http://www.w3.org/1999/xlink">Case</td>
###xml 1540 1544 1540 1544 <td xmlns:xlink="http://www.w3.org/1999/xlink">68.4</td>
###xml 1544 1560 1544 1560 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.24 (1.13&#8211;1.36)</td>
###xml 1568 1570 1568 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 1560 1570 1560 1570 <td xmlns:xlink="http://www.w3.org/1999/xlink">3.9&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td>
###xml 1570 1579 1570 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink">183 (9.7)</td>
###xml 1579 1589 1579 1589 <td xmlns:xlink="http://www.w3.org/1999/xlink">822 (43.8)</td>
###xml 1589 1599 1589 1599 <td xmlns:xlink="http://www.w3.org/1999/xlink">873 (46.5)</td>
###xml 1615 1616 1615 1616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g</sup>
###xml 1599 1616 1599 1616 <td xmlns:xlink="http://www.w3.org/1999/xlink">1.28 (1.16&#8211;1.41)<sup>g</sup></td>
###xml 1624 1626 1624 1626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 1616 1626 1616 1626 <td xmlns:xlink="http://www.w3.org/1999/xlink">2.0&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td>
###xml 1520 1626 1520 1626 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>rs2237897 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>68.4</td><td>1.24 (1.13&#8211;1.36)</td><td>3.9&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td><td>183 (9.7)</td><td>822 (43.8)</td><td>873 (46.5)</td><td>1.28 (1.16&#8211;1.41)<sup>g</sup></td><td>2.0&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr>
###xml 1626 1626 1626 1626 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1626 1633 1626 1633 <td xmlns:xlink="http://www.w3.org/1999/xlink">Control</td>
###xml 1633 1637 1633 1637 <td xmlns:xlink="http://www.w3.org/1999/xlink">63.6</td>
###xml 1637 1637 1637 1637 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1637 1637 1637 1637 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1637 1647 1637 1647 <td xmlns:xlink="http://www.w3.org/1999/xlink">271 (13.6)</td>
###xml 1647 1657 1647 1657 <td xmlns:xlink="http://www.w3.org/1999/xlink">912 (45.7)</td>
###xml 1657 1667 1657 1667 <td xmlns:xlink="http://www.w3.org/1999/xlink">813 (40.7)</td>
###xml 1667 1667 1667 1667 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1667 1667 1667 1667 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1626 1667 1626 1667 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td/><td>Control</td><td>63.6</td><td/><td/><td>271 (13.6)</td><td>912 (45.7)</td><td>813 (40.7)</td><td/><td/></tr>
###xml 1225 1667 1225 1667 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>rs2237892 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>69.6</td><td>1.19 (1.08&#8211;1.31)</td><td>3.0&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>165 (8.8)</td><td>813 (43.2)</td><td>902 (48.0)</td><td>1.23 (1.11&#8211;1.36)<sup>e</sup></td><td>1.1&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td></tr><tr><td/><td>Control</td><td>65.8</td><td/><td/><td>224 (11.2)</td><td>919 (46.0)</td><td>853 (42.7)</td><td/><td/></tr><tr><td>rs2237895 C<sup>c,d</sup>, A</td><td>Case</td><td>34.6</td><td>1.20 (1.09&#8211;1.32)</td><td>1.9&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>209 (11.1)</td><td>886 (47.0)</td><td>790 (41.9)</td><td>1.23 (1.11&#8211;1.37)<sup>f</sup></td><td>7.8&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td></tr><tr><td/><td>Control</td><td>30.6</td><td/><td/><td>169 (8.5)</td><td>883 (44.3)</td><td>942 (47.2)</td><td/><td/></tr><tr><td>rs2237897 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>68.4</td><td>1.24 (1.13&#8211;1.36)</td><td>3.9&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td><td>183 (9.7)</td><td>822 (43.8)</td><td>873 (46.5)</td><td>1.28 (1.16&#8211;1.41)<sup>g</sup></td><td>2.0&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr><tr><td/><td>Control</td><td>63.6</td><td/><td/><td>271 (13.6)</td><td>912 (45.7)</td><td>813 (40.7)</td><td/><td/></tr></tbody>
###xml 1101 1667 1101 1667 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>SNP</th><th rowspan="2">Group</th><th colspan="3">Allele data</th><th colspan="3">Genotype distribution (%)</th><th colspan="2">Additive model</th></tr><tr><th>Allele</th><th>Frequency<sup>a</sup> (%)</th><th>OR (95% CI)</th><th><italic>p</italic> value</th><th>C/C</th><th>C/R</th><th>R/R</th><th>OR (95% CI)</th><th><italic>p</italic> value<sup>b</sup></th></tr></thead><tbody><tr><td>rs2237892 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>69.6</td><td>1.19 (1.08&#8211;1.31)</td><td>3.0&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>165 (8.8)</td><td>813 (43.2)</td><td>902 (48.0)</td><td>1.23 (1.11&#8211;1.36)<sup>e</sup></td><td>1.1&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td></tr><tr><td/><td>Control</td><td>65.8</td><td/><td/><td>224 (11.2)</td><td>919 (46.0)</td><td>853 (42.7)</td><td/><td/></tr><tr><td>rs2237895 C<sup>c,d</sup>, A</td><td>Case</td><td>34.6</td><td>1.20 (1.09&#8211;1.32)</td><td>1.9&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>209 (11.1)</td><td>886 (47.0)</td><td>790 (41.9)</td><td>1.23 (1.11&#8211;1.37)<sup>f</sup></td><td>7.8&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td></tr><tr><td/><td>Control</td><td>30.6</td><td/><td/><td>169 (8.5)</td><td>883 (44.3)</td><td>942 (47.2)</td><td/><td/></tr><tr><td>rs2237897 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>68.4</td><td>1.24 (1.13&#8211;1.36)</td><td>3.9&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td><td>183 (9.7)</td><td>822 (43.8)</td><td>873 (46.5)</td><td>1.28 (1.16&#8211;1.41)<sup>g</sup></td><td>2.0&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr><tr><td/><td>Control</td><td>63.6</td><td/><td/><td>271 (13.6)</td><td>912 (45.7)</td><td>813 (40.7)</td><td/><td/></tr></tbody></table>
###xml 1667 1668 1667 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1667 1689 1667 1689 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26"><sup>a</sup>Risk allele frequency</p>
###xml 1689 1690 1689 1690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1719 1720 1719 1720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 1719 1720 1719 1720 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
###xml 1689 1724 1689 1724 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27"><sup>b</sup>Adjusted for age, sex and log<sub><italic>e</italic></sub> BMI</p>
###xml 1724 1725 1724 1725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1724 1737 1724 1737 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28"><sup>c</sup>Minor allele</p>
###xml 1737 1738 1737 1738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1737 1749 1737 1749 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29"><sup>d</sup>Risk allele</p>
###xml 1759 1760 1759 1760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 1764 1765 1764 1765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f</sup>
###xml 1771 1772 1771 1772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g</sup>
###xml 1749 1776 1749 1776 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">PAR (%)&#8201;=&#8201;<sup>e</sup>23, <sup>f</sup>12.6, <sup>g</sup>27.3</p>
###xml 1776 1879 1776 1879 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">C/C, homozygous for minor allele; C/R, heterozygous for minor allele; R/R, homozygous for common allele</p>
###xml 1667 1879 1667 1879 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26"><sup>a</sup>Risk allele frequency</p><p textid="27"><sup>b</sup>Adjusted for age, sex and log<sub><italic>e</italic></sub> BMI</p><p textid="28"><sup>c</sup>Minor allele</p><p textid="29"><sup>d</sup>Risk allele</p><p textid="30">PAR (%)&#8201;=&#8201;<sup>e</sup>23, <sup>f</sup>12.6, <sup>g</sup>27.3</p><p textid="31">C/C, homozygous for minor allele; C/R, heterozygous for minor allele; R/R, homozygous for common allele</p></table-wrap-foot>
###xml 982 1879 982 1879 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="25">Association of candidate SNPs in <italic>KCNQ1</italic> with type 2 diabetes in participants with type 2 diabetes and in controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th>SNP</th><th rowspan="2">Group</th><th colspan="3">Allele data</th><th colspan="3">Genotype distribution (%)</th><th colspan="2">Additive model</th></tr><tr><th>Allele</th><th>Frequency<sup>a</sup> (%)</th><th>OR (95% CI)</th><th><italic>p</italic> value</th><th>C/C</th><th>C/R</th><th>R/R</th><th>OR (95% CI)</th><th><italic>p</italic> value<sup>b</sup></th></tr></thead><tbody><tr><td>rs2237892 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>69.6</td><td>1.19 (1.08&#8211;1.31)</td><td>3.0&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>165 (8.8)</td><td>813 (43.2)</td><td>902 (48.0)</td><td>1.23 (1.11&#8211;1.36)<sup>e</sup></td><td>1.1&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td></tr><tr><td/><td>Control</td><td>65.8</td><td/><td/><td>224 (11.2)</td><td>919 (46.0)</td><td>853 (42.7)</td><td/><td/></tr><tr><td>rs2237895 C<sup>c,d</sup>, A</td><td>Case</td><td>34.6</td><td>1.20 (1.09&#8211;1.32)</td><td>1.9&#8201;&#215;&#8201;10<sup>&#8722;4</sup></td><td>209 (11.1)</td><td>886 (47.0)</td><td>790 (41.9)</td><td>1.23 (1.11&#8211;1.37)<sup>f</sup></td><td>7.8&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td></tr><tr><td/><td>Control</td><td>30.6</td><td/><td/><td>169 (8.5)</td><td>883 (44.3)</td><td>942 (47.2)</td><td/><td/></tr><tr><td>rs2237897 T<sup>c</sup>, C<sup>d</sup></td><td>Case</td><td>68.4</td><td>1.24 (1.13&#8211;1.36)</td><td>3.9&#8201;&#215;&#8201;10<sup>&#8722;5</sup></td><td>183 (9.7)</td><td>822 (43.8)</td><td>873 (46.5)</td><td>1.28 (1.16&#8211;1.41)<sup>g</sup></td><td>2.0&#8201;&#215;&#8201;10<sup>&#8722;6</sup></td></tr><tr><td/><td>Control</td><td>63.6</td><td/><td/><td>271 (13.6)</td><td>912 (45.7)</td><td>813 (40.7)</td><td/><td/></tr></tbody></table><table-wrap-foot><p textid="26"><sup>a</sup>Risk allele frequency</p><p textid="27"><sup>b</sup>Adjusted for age, sex and log<sub><italic>e</italic></sub> BMI</p><p textid="28"><sup>c</sup>Minor allele</p><p textid="29"><sup>d</sup>Risk allele</p><p textid="30">PAR (%)&#8201;=&#8201;<sup>e</sup>23, <sup>f</sup>12.6, <sup>g</sup>27.3</p><p textid="31">C/C, homozygous for minor allele; C/R, heterozygous for minor allele; R/R, homozygous for common allele</p></table-wrap-foot></table-wrap>
###xml 1052 1064 <span type="species:ncbi:9606">participants</span>
The allele and genotype distribution are summarised in Table 2. All three variants genotyped were in Hardy-Weinberg equilibrium in both the case and control groups. Allele frequency ORs of the three SNPs, rs2237892 (OR 1.19, 95% CI 1.08-1.31, p = 3.0 x 10-4), rs2237895 (OR 1.20, 95% CI 1.09-1.32, p = 1.9 x 10-4) and rs2237897 (OR 1.24, 95% CI 1.13-1.36, p = 3.9 x 10-5) were significantly associated with type 2 diabetes in our sample. The risk alleles were in the same direction as in previous studies [18, 19]. The best-fitting genetic model for all three was the additive model (see Electronic supplementary material [ESM] Table 1). Under the additive model with adjustment for age, sex and loge BMI, significant association was detected in all three polymorphisms (rs2237892, OR 1.23, 95% CI 1.11-1.36, p = 1.1 x 10-4, PAR = 23.9%; rs2237895, OR 1.23, 95% CI 1.11-1.37, p = 7.8 x 10-5, PAR = 12.6%; rs2237897, OR 1.28, 95% CI 1.16-1.41, p = 2.0 x 10-6, PAR = 27.3%; Table 2). Table 2Association of candidate SNPs in KCNQ1 with type 2 diabetes in participants with type 2 diabetes and in controlsSNPGroupAllele dataGenotype distribution (%)Additive modelAlleleFrequencya (%)OR (95% CI)p valueC/CC/RR/ROR (95% CI)p valuebrs2237892 Tc, CdCase69.61.19 (1.08-1.31)3.0 x 10-4165 (8.8)813 (43.2)902 (48.0)1.23 (1.11-1.36)e1.1 x 10-4Control65.8224 (11.2)919 (46.0)853 (42.7)rs2237895 Cc,d, ACase34.61.20 (1.09-1.32)1.9 x 10-4209 (11.1)886 (47.0)790 (41.9)1.23 (1.11-1.37)f7.8 x 10-5Control30.6169 (8.5)883 (44.3)942 (47.2)rs2237897 Tc, CdCase68.41.24 (1.13-1.36)3.9 x 10-5183 (9.7)822 (43.8)873 (46.5)1.28 (1.16-1.41)g2.0 x 10-6Control63.6271 (13.6)912 (45.7)813 (40.7)aRisk allele frequencybAdjusted for age, sex and loge BMIcMinor alleledRisk allelePAR (%) = e23, f12.6, g27.3C/C, homozygous for minor allele; C/R, heterozygous for minor allele; R/R, homozygous for common allele
###end p 24
###begin p 25
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 63 75 <span type="species:ncbi:9606">participants</span>
Association of candidate SNPs in KCNQ1 with type 2 diabetes in participants with type 2 diabetes and in controls
###end p 25
###begin p 26
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aRisk allele frequency
###end p 26
###begin p 27
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
bAdjusted for age, sex and loge BMI
###end p 27
###begin p 28
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
cMinor allele
###end p 28
###begin p 29
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
dRisk allele
###end p 29
###begin p 30
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">g</sup>
PAR (%) = e23, f12.6, g27.3
###end p 30
###begin p 31
C/C, homozygous for minor allele; C/R, heterozygous for minor allele; R/R, homozygous for common allele
###end p 31
###begin p 32
###xml 66 67 66 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 86 88 86 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM2">2</xref>
###xml 546 547 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 558 560 558 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 619 620 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 631 633 631 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 694 695 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 706 708 706 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM3">3</xref>
###xml 795 801 795 801 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 849 854 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 865 867 865 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 898 900 898 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 922 924 922 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 985 987 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 801 1096 801 1096 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Linkage disequilibrium structure of the SNPs in <italic>KCNQ1</italic>. Pairwise <italic>D&#8242;</italic> values are colour coded: high <italic>D&#8242;</italic> values are dark, low <italic>D&#8242;</italic> values are light (values were generated by SHEsis software [<xref ref-type="bibr" rid="CR22">22</xref>]). The numbers shown at the top represent the degrees of the location of the region on chromosome 11 (Chr11)</p>
###xml 801 1096 801 1096 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Linkage disequilibrium structure of the SNPs in <italic>KCNQ1</italic>. Pairwise <italic>D&#8242;</italic> values are colour coded: high <italic>D&#8242;</italic> values are dark, low <italic>D&#8242;</italic> values are light (values were generated by SHEsis software [<xref ref-type="bibr" rid="CR22">22</xref>]). The numbers shown at the top represent the degrees of the location of the region on chromosome 11 (Chr11)</p></caption>
###xml 1096 1096 1096 1096 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2009_1375_Fig1_HTML" id="MO1"/>
###xml 795 1096 795 1096 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="33">Linkage disequilibrium structure of the SNPs in <italic>KCNQ1</italic>. Pairwise <italic>D&#8242;</italic> values are colour coded: high <italic>D&#8242;</italic> values are dark, low <italic>D&#8242;</italic> values are light (values were generated by SHEsis software [<xref ref-type="bibr" rid="CR22">22</xref>]). The numbers shown at the top represent the degrees of the location of the region on chromosome 11 (Chr11)</p></caption><graphic position="anchor" xlink:href="125_2009_1375_Fig1_HTML" id="MO1"/></fig>
The LD structure (rs2237892/rs2237895/rs2237897) is shown in Fig. 1. LD coefficients (D' and r2) among the three variants (see ESM Table 2) suggested that the degree of linkage disequilibrium was relatively high. So haplotypes were constructed with all three variants and the frequencies of haplotypes were then analysed by excluding the rare haplotypes (those below 2% frequency in cases or controls); this revealed a significant difference in the distribution of the global haplotypes between the type 2 diabetes group and the normal controls (p = 2.6 x 10-5). The C-C-C haplotype frequency was significantly higher (p = 2.1 x 10-3) and the T-A-T haplotype frequency was significantly lower (p = 4.0 x 10-5) in the group with type 2 diabetes compared with the control group (see ESM Table 3). Fig. 1Linkage disequilibrium structure of the SNPs in KCNQ1. Pairwise D' values are colour coded: high D' values are dark, low D' values are light (values were generated by SHEsis software [22]). The numbers shown at the top represent the degrees of the location of the region on chromosome 11 (Chr11)
###end p 32
###begin p 33
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 64 66 64 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 97 99 97 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
Linkage disequilibrium structure of the SNPs in KCNQ1. Pairwise D' values are colour coded: high D' values are dark, low D' values are light (values were generated by SHEsis software [22]). The numbers shown at the top represent the degrees of the location of the region on chromosome 11 (Chr11)
###end p 33
###begin p 34
###xml 383 385 383 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 604 611 604 611 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 611 713 611 713 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Effect of candidate SNP variant genotypes on clinical and biochemical variables in control individuals</p>
###xml 611 713 611 713 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Effect of candidate SNP variant genotypes on clinical and biochemical variables in control individuals</p></caption>
###xml 713 716 713 716 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">SNP</th>
###xml 716 727 716 727 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Risk allele</th>
###xml 727 742 727 742 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Non-risk allele</th>
###xml 767 768 767 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 742 768 742 768 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">Phenotypic characteristic<sup>a</sup></th>
###xml 768 777 768 777 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Genotypes</th>
###xml 777 778 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 784 785 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 777 785 777 785 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3"><italic>p</italic> value<sup>b</sup></th>
###xml 713 785 713 785 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">SNP</th><th rowspan="2">Risk allele</th><th rowspan="2">Non-risk allele</th><th rowspan="2">Phenotypic characteristic<sup>a</sup></th><th colspan="3">Genotypes</th><th colspan="3"><italic>p</italic> value<sup>b</sup></th></tr>
###xml 785 788 785 788 <th xmlns:xlink="http://www.w3.org/1999/xlink">C/C</th>
###xml 788 791 788 791 <th xmlns:xlink="http://www.w3.org/1999/xlink">C/R</th>
###xml 791 794 791 794 <th xmlns:xlink="http://www.w3.org/1999/xlink">R/R</th>
###xml 794 802 794 802 <th xmlns:xlink="http://www.w3.org/1999/xlink">Additive</th>
###xml 802 810 802 810 <th xmlns:xlink="http://www.w3.org/1999/xlink">Dominant</th>
###xml 810 819 810 819 <th xmlns:xlink="http://www.w3.org/1999/xlink">Recessive</th>
###xml 785 819 785 819 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>C/C</th><th>C/R</th><th>R/R</th><th>Additive</th><th>Dominant</th><th>Recessive</th></tr>
###xml 713 819 713 819 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">SNP</th><th rowspan="2">Risk allele</th><th rowspan="2">Non-risk allele</th><th rowspan="2">Phenotypic characteristic<sup>a</sup></th><th colspan="3">Genotypes</th><th colspan="3"><italic>p</italic> value<sup>b</sup></th></tr><tr><th>C/C</th><th>C/R</th><th>R/R</th><th>Additive</th><th>Dominant</th><th>Recessive</th></tr></thead>
###xml 819 828 819 828 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">rs2237892</td>
###xml 828 829 828 829 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">C</td>
###xml 829 830 829 830 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">T</td>
###xml 839 840 839 840 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 830 841 830 841 <td xmlns:xlink="http://www.w3.org/1999/xlink">BMI (kg/m<sup>2</sup>)</td>
###xml 841 854 841 852 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.3&#8201;&#177;&#8201;3.13</td>
###xml 854 867 852 863 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.7&#8201;&#177;&#8201;3.30</td>
###xml 867 880 863 874 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.7&#8201;&#177;&#8201;3.42</td>
###xml 880 885 874 879 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.039</td>
###xml 885 890 879 884 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.483</td>
###xml 890 895 884 889 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.020</td>
###xml 819 895 819 889 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="7">rs2237892</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.3&#8201;&#177;&#8201;3.13</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.30</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.42</td><td char="." align="char">0.039</td><td char="." align="char">0.483</td><td char="." align="char">0.020</td></tr>
###xml 895 905 889 899 <td xmlns:xlink="http://www.w3.org/1999/xlink">Waist (cm)</td>
###xml 905 918 899 910 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">82.9&#8201;&#177;&#8201;9.08</td>
###xml 918 931 910 921 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">83.2&#8201;&#177;&#8201;8.79</td>
###xml 931 944 921 932 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">84.9&#8201;&#177;&#8201;16.3</td>
###xml 944 949 932 937 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.043</td>
###xml 949 954 937 942 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.019</td>
###xml 954 959 942 947 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.223</td>
###xml 895 959 889 947 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Waist (cm)</td><td char="&#177;" align="char">82.9&#8201;&#177;&#8201;9.08</td><td char="&#177;" align="char">83.2&#8201;&#177;&#8201;8.79</td><td char="&#177;" align="char">84.9&#8201;&#177;&#8201;16.3</td><td char="." align="char">0.043</td><td char="." align="char">0.019</td><td char="." align="char">0.223</td></tr>
###xml 959 977 947 965 <td xmlns:xlink="http://www.w3.org/1999/xlink">Waist to hip ratio</td>
###xml 977 990 965 976 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.06</td>
###xml 990 1003 976 987 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.07</td>
###xml 1003 1016 987 998 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.07</td>
###xml 1016 1021 998 1003 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.635</td>
###xml 1021 1026 1003 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.492</td>
###xml 1026 1031 1008 1013 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.844</td>
###xml 959 1031 947 1013 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="." align="char">0.635</td><td char="." align="char">0.492</td><td char="." align="char">0.844</td></tr>
###xml 1031 1062 1013 1044 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fasting plasma glucose (mmol/l)</td>
###xml 1062 1075 1044 1055 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.85&#8201;&#177;&#8201;0.66</td>
###xml 1075 1088 1055 1066 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.83&#8201;&#177;&#8201;0.60</td>
###xml 1088 1101 1066 1077 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.75&#8201;&#177;&#8201;0.71</td>
###xml 1101 1106 1077 1082 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.051</td>
###xml 1106 1111 1082 1087 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.047</td>
###xml 1111 1116 1087 1092 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.190</td>
###xml 1031 1116 1013 1092 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.83&#8201;&#177;&#8201;0.60</td><td char="&#177;" align="char">4.75&#8201;&#177;&#8201;0.71</td><td char="." align="char">0.051</td><td char="." align="char">0.047</td><td char="." align="char">0.190</td></tr>
###xml 1119 1121 1095 1097 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1116 1125 1092 1101 <td xmlns:xlink="http://www.w3.org/1999/xlink">HbA<sub>1c</sub> (%)</td>
###xml 1125 1138 1101 1112 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.81&#8201;&#177;&#8201;0.55</td>
###xml 1138 1151 1112 1123 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.75&#8201;&#177;&#8201;0.53</td>
###xml 1151 1164 1123 1134 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.77&#8201;&#177;&#8201;0.69</td>
###xml 1164 1169 1134 1139 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.064</td>
###xml 1169 1174 1139 1144 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.781</td>
###xml 1174 1179 1144 1149 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.012</td>
###xml 1116 1179 1092 1149 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.81&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.69</td><td char="." align="char">0.064</td><td char="." align="char">0.781</td><td char="." align="char">0.012</td></tr>
###xml 1179 1205 1149 1175 <td xmlns:xlink="http://www.w3.org/1999/xlink">Total cholesterol (mmol/l)</td>
###xml 1205 1218 1175 1186 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.52&#8201;&#177;&#8201;0.90</td>
###xml 1218 1231 1186 1197 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.48&#8201;&#177;&#8201;0.88</td>
###xml 1231 1244 1197 1208 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.53&#8201;&#177;&#8201;0.80</td>
###xml 1244 1249 1208 1213 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.517</td>
###xml 1249 1254 1213 1218 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.583</td>
###xml 1254 1259 1218 1223 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.221</td>
###xml 1179 1259 1149 1223 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.48&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.53&#8201;&#177;&#8201;0.80</td><td char="." align="char">0.517</td><td char="." align="char">0.583</td><td char="." align="char">0.221</td></tr>
###xml 1259 1283 1223 1247 <td xmlns:xlink="http://www.w3.org/1999/xlink">Triacylglycerol (mmol/l)</td>
###xml 1283 1296 1247 1258 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.64&#8201;&#177;&#8201;1.08</td>
###xml 1296 1309 1258 1269 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.58&#8201;&#177;&#8201;1.10</td>
###xml 1309 1322 1269 1280 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.60&#8201;&#177;&#8201;0.85</td>
###xml 1322 1327 1280 1285 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.404</td>
###xml 1327 1332 1285 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.978</td>
###xml 1332 1337 1290 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.255</td>
###xml 1259 1337 1223 1295 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.64&#8201;&#177;&#8201;1.08</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.60&#8201;&#177;&#8201;0.85</td><td char="." align="char">0.404</td><td char="." align="char">0.978</td><td char="." align="char">0.255</td></tr>
###xml 1337 1346 1295 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">rs2237895</td>
###xml 1346 1347 1304 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">C</td>
###xml 1347 1348 1305 1306 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">A</td>
###xml 1357 1358 1315 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1348 1359 1306 1317 <td xmlns:xlink="http://www.w3.org/1999/xlink">BMI (kg/m<sup>2</sup>)</td>
###xml 1359 1372 1317 1328 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">23.9&#8201;&#177;&#8201;2.86</td>
###xml 1372 1385 1328 1339 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.5&#8201;&#177;&#8201;3.34</td>
###xml 1385 1398 1339 1350 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.6&#8201;&#177;&#8201;3.22</td>
###xml 1398 1403 1350 1355 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.027</td>
###xml 1403 1408 1355 1360 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.200</td>
###xml 1408 1413 1360 1365 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.006</td>
###xml 1337 1413 1295 1365 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="7">rs2237895</td><td rowspan="7">C</td><td rowspan="7">A</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">23.9&#8201;&#177;&#8201;2.86</td><td char="&#177;" align="char">24.5&#8201;&#177;&#8201;3.34</td><td char="&#177;" align="char">24.6&#8201;&#177;&#8201;3.22</td><td char="." align="char">0.027</td><td char="." align="char">0.200</td><td char="." align="char">0.006</td></tr>
###xml 1413 1423 1365 1375 <td xmlns:xlink="http://www.w3.org/1999/xlink">Waist (cm)</td>
###xml 1423 1436 1375 1386 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">82.0&#8201;&#177;&#8201;8.47</td>
###xml 1436 1449 1386 1397 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">83.0&#8201;&#177;&#8201;9.06</td>
###xml 1449 1462 1397 1408 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">83.8&#8201;&#177;&#8201;11.1</td>
###xml 1462 1467 1408 1413 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.012</td>
###xml 1467 1472 1413 1418 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.036</td>
###xml 1472 1477 1418 1423 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.048</td>
###xml 1413 1477 1365 1423 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Waist (cm)</td><td char="&#177;" align="char">82.0&#8201;&#177;&#8201;8.47</td><td char="&#177;" align="char">83.0&#8201;&#177;&#8201;9.06</td><td char="&#177;" align="char">83.8&#8201;&#177;&#8201;11.1</td><td char="." align="char">0.012</td><td char="." align="char">0.036</td><td char="." align="char">0.048</td></tr>
###xml 1477 1495 1423 1441 <td xmlns:xlink="http://www.w3.org/1999/xlink">Waist to hip ratio</td>
###xml 1495 1508 1441 1452 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.05</td>
###xml 1508 1521 1452 1463 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.06</td>
###xml 1521 1534 1463 1474 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.06</td>
###xml 1534 1539 1474 1479 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.093</td>
###xml 1539 1544 1479 1484 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.058</td>
###xml 1544 1549 1484 1489 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.655</td>
###xml 1477 1549 1423 1489 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.05</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.093</td><td char="." align="char">0.058</td><td char="." align="char">0.655</td></tr>
###xml 1549 1580 1489 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fasting plasma glucose (mmol/l)</td>
###xml 1580 1593 1520 1531 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.82&#8201;&#177;&#8201;0.69</td>
###xml 1593 1606 1531 1542 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.85&#8201;&#177;&#8201;0.62</td>
###xml 1606 1619 1542 1553 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.81&#8201;&#177;&#8201;0.65</td>
###xml 1619 1624 1553 1558 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.188</td>
###xml 1624 1629 1558 1563 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.081</td>
###xml 1629 1634 1563 1568 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.913</td>
###xml 1549 1634 1489 1568 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.69</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.62</td><td char="&#177;" align="char">4.81&#8201;&#177;&#8201;0.65</td><td char="." align="char">0.188</td><td char="." align="char">0.081</td><td char="." align="char">0.913</td></tr>
###xml 1637 1639 1571 1573 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1634 1643 1568 1577 <td xmlns:xlink="http://www.w3.org/1999/xlink">HbA<sub>1c</sub> (%)</td>
###xml 1643 1656 1577 1588 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.75&#8201;&#177;&#8201;0.57</td>
###xml 1656 1669 1588 1599 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.78&#8201;&#177;&#8201;0.55</td>
###xml 1669 1682 1599 1610 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.79&#8201;&#177;&#8201;0.57</td>
###xml 1682 1687 1610 1615 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.651</td>
###xml 1687 1692 1615 1620 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.779</td>
###xml 1692 1697 1620 1625 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.595</td>
###xml 1634 1697 1568 1625 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.57</td><td char="&#177;" align="char">5.78&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.79&#8201;&#177;&#8201;0.57</td><td char="." align="char">0.651</td><td char="." align="char">0.779</td><td char="." align="char">0.595</td></tr>
###xml 1697 1723 1625 1651 <td xmlns:xlink="http://www.w3.org/1999/xlink">Total cholesterol (mmol/l)</td>
###xml 1723 1736 1651 1662 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.42&#8201;&#177;&#8201;0.84</td>
###xml 1736 1749 1662 1673 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.51&#8201;&#177;&#8201;0.88</td>
###xml 1749 1762 1673 1684 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.51&#8201;&#177;&#8201;0.88</td>
###xml 1762 1767 1684 1689 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.748</td>
###xml 1767 1772 1689 1694 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.811</td>
###xml 1772 1777 1694 1699 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.245</td>
###xml 1697 1777 1625 1699 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.42&#8201;&#177;&#8201;0.84</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="." align="char">0.748</td><td char="." align="char">0.811</td><td char="." align="char">0.245</td></tr>
###xml 1777 1801 1699 1723 <td xmlns:xlink="http://www.w3.org/1999/xlink">Triacylglycerol (mmol/l)</td>
###xml 1801 1814 1723 1734 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.59&#8201;&#177;&#8201;1.10</td>
###xml 1814 1827 1734 1745 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.61&#8201;&#177;&#8201;1.03</td>
###xml 1827 1840 1745 1756 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.61&#8201;&#177;&#8201;1.09</td>
###xml 1840 1845 1756 1761 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.986</td>
###xml 1845 1850 1761 1766 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.831</td>
###xml 1850 1855 1766 1771 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.733</td>
###xml 1777 1855 1699 1771 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.59&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.09</td><td char="." align="char">0.986</td><td char="." align="char">0.831</td><td char="." align="char">0.733</td></tr>
###xml 1855 1864 1771 1780 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">rs2237897</td>
###xml 1864 1865 1780 1781 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">C</td>
###xml 1865 1866 1781 1782 <td xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="7">T</td>
###xml 1875 1876 1791 1792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1866 1877 1782 1793 <td xmlns:xlink="http://www.w3.org/1999/xlink">BMI (kg/m<sup>2</sup>)</td>
###xml 1877 1890 1793 1804 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.2&#8201;&#177;&#8201;3.15</td>
###xml 1890 1903 1804 1815 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.7&#8201;&#177;&#8201;3.28</td>
###xml 1903 1916 1815 1826 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">24.9&#8201;&#177;&#8201;3.36</td>
###xml 1916 1921 1826 1831 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.002</td>
###xml 1921 1926 1831 1836 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.074</td>
###xml 1926 1931 1836 1841 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.002</td>
###xml 1855 1931 1771 1841 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td rowspan="7">rs2237897</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.2&#8201;&#177;&#8201;3.15</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.28</td><td char="&#177;" align="char">24.9&#8201;&#177;&#8201;3.36</td><td char="." align="char">0.002</td><td char="." align="char">0.074</td><td char="." align="char">0.002</td></tr>
###xml 1931 1941 1841 1851 <td xmlns:xlink="http://www.w3.org/1999/xlink">Waist (cm)</td>
###xml 1941 1954 1851 1862 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">82.7&#8201;&#177;&#8201;9.13</td>
###xml 1954 1967 1862 1873 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">83.5&#8201;&#177;&#8201;8.80</td>
###xml 1967 1980 1873 1884 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">84.6&#8201;&#177;&#8201;15.2</td>
###xml 1980 1985 1884 1889 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.004</td>
###xml 1985 1990 1889 1894 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.017</td>
###xml 1990 1995 1894 1899 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.018</td>
###xml 1931 1995 1841 1899 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Waist (cm)</td><td char="&#177;" align="char">82.7&#8201;&#177;&#8201;9.13</td><td char="&#177;" align="char">83.5&#8201;&#177;&#8201;8.80</td><td char="&#177;" align="char">84.6&#8201;&#177;&#8201;15.2</td><td char="." align="char">0.004</td><td char="." align="char">0.017</td><td char="." align="char">0.018</td></tr>
###xml 1995 2013 1899 1917 <td xmlns:xlink="http://www.w3.org/1999/xlink">Waist to hip ratio</td>
###xml 2013 2026 1917 1928 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.06</td>
###xml 2026 2039 1928 1939 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.06</td>
###xml 2039 2052 1939 1950 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">0.86&#8201;&#177;&#8201;0.06</td>
###xml 2052 2057 1950 1955 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.576</td>
###xml 2057 2062 1955 1960 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.703</td>
###xml 2062 2067 1960 1965 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.608</td>
###xml 1995 2067 1899 1965 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.576</td><td char="." align="char">0.703</td><td char="." align="char">0.608</td></tr>
###xml 2067 2098 1965 1996 <td xmlns:xlink="http://www.w3.org/1999/xlink">Fasting plasma glucose (mmol/l)</td>
###xml 2098 2111 1996 2007 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.82&#8201;&#177;&#8201;0.66</td>
###xml 2111 2124 2007 2018 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.85&#8201;&#177;&#8201;0.61</td>
###xml 2124 2137 2018 2029 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.77&#8201;&#177;&#8201;0.68</td>
###xml 2137 2142 2029 2034 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.562</td>
###xml 2142 2147 2034 2039 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.155</td>
###xml 2147 2152 2039 2044 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.854</td>
###xml 2067 2152 1965 2044 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.61</td><td char="&#177;" align="char">4.77&#8201;&#177;&#8201;0.68</td><td char="." align="char">0.562</td><td char="." align="char">0.155</td><td char="." align="char">0.854</td></tr>
###xml 2155 2157 2047 2049 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 2152 2161 2044 2053 <td xmlns:xlink="http://www.w3.org/1999/xlink">HbA<sub>1c</sub> (%)</td>
###xml 2161 2174 2053 2064 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.80&#8201;&#177;&#8201;0.55</td>
###xml 2174 2187 2064 2075 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.76&#8201;&#177;&#8201;0.53</td>
###xml 2187 2200 2075 2086 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">5.77&#8201;&#177;&#8201;0.66</td>
###xml 2200 2205 2086 2091 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.133</td>
###xml 2205 2210 2091 2096 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.662</td>
###xml 2210 2215 2096 2101 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.047</td>
###xml 2152 2215 2044 2101 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.80&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.76&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.66</td><td char="." align="char">0.133</td><td char="." align="char">0.662</td><td char="." align="char">0.047</td></tr>
###xml 2215 2241 2101 2127 <td xmlns:xlink="http://www.w3.org/1999/xlink">Total cholesterol (mmol/l)</td>
###xml 2241 2254 2127 2138 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.52&#8201;&#177;&#8201;0.90</td>
###xml 2254 2267 2138 2149 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.47&#8201;&#177;&#8201;0.87</td>
###xml 2267 2280 2149 2160 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">4.56&#8201;&#177;&#8201;0.83</td>
###xml 2280 2285 2160 2165 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.630</td>
###xml 2285 2290 2165 2170 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.368</td>
###xml 2290 2295 2170 2175 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.193</td>
###xml 2215 2295 2101 2175 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.47&#8201;&#177;&#8201;0.87</td><td char="&#177;" align="char">4.56&#8201;&#177;&#8201;0.83</td><td char="." align="char">0.630</td><td char="." align="char">0.368</td><td char="." align="char">0.193</td></tr>
###xml 2295 2319 2175 2199 <td xmlns:xlink="http://www.w3.org/1999/xlink">Triacylglycerol (mmol/l)</td>
###xml 2319 2332 2199 2210 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.63&#8201;&#177;&#8201;1.11</td>
###xml 2332 2345 2210 2221 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.58&#8201;&#177;&#8201;1.03</td>
###xml 2345 2358 2221 2232 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">1.67&#8201;&#177;&#8201;1.18</td>
###xml 2358 2363 2232 2237 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.991</td>
###xml 2363 2368 2237 2242 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.332</td>
###xml 2368 2373 2242 2247 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.508</td>
###xml 2295 2373 2175 2247 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;1.11</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.67&#8201;&#177;&#8201;1.18</td><td char="." align="char">0.991</td><td char="." align="char">0.332</td><td char="." align="char">0.508</td></tr>
###xml 819 2373 819 2247 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td rowspan="7">rs2237892</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.3&#8201;&#177;&#8201;3.13</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.30</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.42</td><td char="." align="char">0.039</td><td char="." align="char">0.483</td><td char="." align="char">0.020</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.9&#8201;&#177;&#8201;9.08</td><td char="&#177;" align="char">83.2&#8201;&#177;&#8201;8.79</td><td char="&#177;" align="char">84.9&#8201;&#177;&#8201;16.3</td><td char="." align="char">0.043</td><td char="." align="char">0.019</td><td char="." align="char">0.223</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="." align="char">0.635</td><td char="." align="char">0.492</td><td char="." align="char">0.844</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.83&#8201;&#177;&#8201;0.60</td><td char="&#177;" align="char">4.75&#8201;&#177;&#8201;0.71</td><td char="." align="char">0.051</td><td char="." align="char">0.047</td><td char="." align="char">0.190</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.81&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.69</td><td char="." align="char">0.064</td><td char="." align="char">0.781</td><td char="." align="char">0.012</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.48&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.53&#8201;&#177;&#8201;0.80</td><td char="." align="char">0.517</td><td char="." align="char">0.583</td><td char="." align="char">0.221</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.64&#8201;&#177;&#8201;1.08</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.60&#8201;&#177;&#8201;0.85</td><td char="." align="char">0.404</td><td char="." align="char">0.978</td><td char="." align="char">0.255</td></tr><tr><td rowspan="7">rs2237895</td><td rowspan="7">C</td><td rowspan="7">A</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">23.9&#8201;&#177;&#8201;2.86</td><td char="&#177;" align="char">24.5&#8201;&#177;&#8201;3.34</td><td char="&#177;" align="char">24.6&#8201;&#177;&#8201;3.22</td><td char="." align="char">0.027</td><td char="." align="char">0.200</td><td char="." align="char">0.006</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.0&#8201;&#177;&#8201;8.47</td><td char="&#177;" align="char">83.0&#8201;&#177;&#8201;9.06</td><td char="&#177;" align="char">83.8&#8201;&#177;&#8201;11.1</td><td char="." align="char">0.012</td><td char="." align="char">0.036</td><td char="." align="char">0.048</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.05</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.093</td><td char="." align="char">0.058</td><td char="." align="char">0.655</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.69</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.62</td><td char="&#177;" align="char">4.81&#8201;&#177;&#8201;0.65</td><td char="." align="char">0.188</td><td char="." align="char">0.081</td><td char="." align="char">0.913</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.57</td><td char="&#177;" align="char">5.78&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.79&#8201;&#177;&#8201;0.57</td><td char="." align="char">0.651</td><td char="." align="char">0.779</td><td char="." align="char">0.595</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.42&#8201;&#177;&#8201;0.84</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="." align="char">0.748</td><td char="." align="char">0.811</td><td char="." align="char">0.245</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.59&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.09</td><td char="." align="char">0.986</td><td char="." align="char">0.831</td><td char="." align="char">0.733</td></tr><tr><td rowspan="7">rs2237897</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.2&#8201;&#177;&#8201;3.15</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.28</td><td char="&#177;" align="char">24.9&#8201;&#177;&#8201;3.36</td><td char="." align="char">0.002</td><td char="." align="char">0.074</td><td char="." align="char">0.002</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.7&#8201;&#177;&#8201;9.13</td><td char="&#177;" align="char">83.5&#8201;&#177;&#8201;8.80</td><td char="&#177;" align="char">84.6&#8201;&#177;&#8201;15.2</td><td char="." align="char">0.004</td><td char="." align="char">0.017</td><td char="." align="char">0.018</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.576</td><td char="." align="char">0.703</td><td char="." align="char">0.608</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.61</td><td char="&#177;" align="char">4.77&#8201;&#177;&#8201;0.68</td><td char="." align="char">0.562</td><td char="." align="char">0.155</td><td char="." align="char">0.854</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.80&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.76&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.66</td><td char="." align="char">0.133</td><td char="." align="char">0.662</td><td char="." align="char">0.047</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.47&#8201;&#177;&#8201;0.87</td><td char="&#177;" align="char">4.56&#8201;&#177;&#8201;0.83</td><td char="." align="char">0.630</td><td char="." align="char">0.368</td><td char="." align="char">0.193</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;1.11</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.67&#8201;&#177;&#8201;1.18</td><td char="." align="char">0.991</td><td char="." align="char">0.332</td><td char="." align="char">0.508</td></tr></tbody>
###xml 713 2373 713 2247 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">SNP</th><th rowspan="2">Risk allele</th><th rowspan="2">Non-risk allele</th><th rowspan="2">Phenotypic characteristic<sup>a</sup></th><th colspan="3">Genotypes</th><th colspan="3"><italic>p</italic> value<sup>b</sup></th></tr><tr><th>C/C</th><th>C/R</th><th>R/R</th><th>Additive</th><th>Dominant</th><th>Recessive</th></tr></thead><tbody><tr><td rowspan="7">rs2237892</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.3&#8201;&#177;&#8201;3.13</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.30</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.42</td><td char="." align="char">0.039</td><td char="." align="char">0.483</td><td char="." align="char">0.020</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.9&#8201;&#177;&#8201;9.08</td><td char="&#177;" align="char">83.2&#8201;&#177;&#8201;8.79</td><td char="&#177;" align="char">84.9&#8201;&#177;&#8201;16.3</td><td char="." align="char">0.043</td><td char="." align="char">0.019</td><td char="." align="char">0.223</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="." align="char">0.635</td><td char="." align="char">0.492</td><td char="." align="char">0.844</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.83&#8201;&#177;&#8201;0.60</td><td char="&#177;" align="char">4.75&#8201;&#177;&#8201;0.71</td><td char="." align="char">0.051</td><td char="." align="char">0.047</td><td char="." align="char">0.190</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.81&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.69</td><td char="." align="char">0.064</td><td char="." align="char">0.781</td><td char="." align="char">0.012</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.48&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.53&#8201;&#177;&#8201;0.80</td><td char="." align="char">0.517</td><td char="." align="char">0.583</td><td char="." align="char">0.221</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.64&#8201;&#177;&#8201;1.08</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.60&#8201;&#177;&#8201;0.85</td><td char="." align="char">0.404</td><td char="." align="char">0.978</td><td char="." align="char">0.255</td></tr><tr><td rowspan="7">rs2237895</td><td rowspan="7">C</td><td rowspan="7">A</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">23.9&#8201;&#177;&#8201;2.86</td><td char="&#177;" align="char">24.5&#8201;&#177;&#8201;3.34</td><td char="&#177;" align="char">24.6&#8201;&#177;&#8201;3.22</td><td char="." align="char">0.027</td><td char="." align="char">0.200</td><td char="." align="char">0.006</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.0&#8201;&#177;&#8201;8.47</td><td char="&#177;" align="char">83.0&#8201;&#177;&#8201;9.06</td><td char="&#177;" align="char">83.8&#8201;&#177;&#8201;11.1</td><td char="." align="char">0.012</td><td char="." align="char">0.036</td><td char="." align="char">0.048</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.05</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.093</td><td char="." align="char">0.058</td><td char="." align="char">0.655</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.69</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.62</td><td char="&#177;" align="char">4.81&#8201;&#177;&#8201;0.65</td><td char="." align="char">0.188</td><td char="." align="char">0.081</td><td char="." align="char">0.913</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.57</td><td char="&#177;" align="char">5.78&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.79&#8201;&#177;&#8201;0.57</td><td char="." align="char">0.651</td><td char="." align="char">0.779</td><td char="." align="char">0.595</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.42&#8201;&#177;&#8201;0.84</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="." align="char">0.748</td><td char="." align="char">0.811</td><td char="." align="char">0.245</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.59&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.09</td><td char="." align="char">0.986</td><td char="." align="char">0.831</td><td char="." align="char">0.733</td></tr><tr><td rowspan="7">rs2237897</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.2&#8201;&#177;&#8201;3.15</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.28</td><td char="&#177;" align="char">24.9&#8201;&#177;&#8201;3.36</td><td char="." align="char">0.002</td><td char="." align="char">0.074</td><td char="." align="char">0.002</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.7&#8201;&#177;&#8201;9.13</td><td char="&#177;" align="char">83.5&#8201;&#177;&#8201;8.80</td><td char="&#177;" align="char">84.6&#8201;&#177;&#8201;15.2</td><td char="." align="char">0.004</td><td char="." align="char">0.017</td><td char="." align="char">0.018</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.576</td><td char="." align="char">0.703</td><td char="." align="char">0.608</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.61</td><td char="&#177;" align="char">4.77&#8201;&#177;&#8201;0.68</td><td char="." align="char">0.562</td><td char="." align="char">0.155</td><td char="." align="char">0.854</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.80&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.76&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.66</td><td char="." align="char">0.133</td><td char="." align="char">0.662</td><td char="." align="char">0.047</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.47&#8201;&#177;&#8201;0.87</td><td char="&#177;" align="char">4.56&#8201;&#177;&#8201;0.83</td><td char="." align="char">0.630</td><td char="." align="char">0.368</td><td char="." align="char">0.193</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;1.11</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.67&#8201;&#177;&#8201;1.18</td><td char="." align="char">0.991</td><td char="." align="char">0.332</td><td char="." align="char">0.508</td></tr></tbody></table>
###xml 2373 2394 2247 2266 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">Data are means&#8201;&#177;&#8201;SD</p>
###xml 2394 2395 2266 2267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2394 2506 2266 2378 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><sup>a</sup>Multiple linear regression was carried out after logarithmic transformation for data not in normal distribution</p>
###xml 2506 2507 2378 2379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2588 2589 2460 2461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 2588 2589 2460 2461 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
###xml 2506 2612 2378 2484 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><sup>b</sup>Adjusted for age and sex (BMI, waist and waist to hip ratio), or age, sex and log<sub><italic>e</italic></sub> BMI (all other traits)</p>
###xml 2612 2715 2484 2587 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">C/C, homozygous for risk allele; C/R, heterozygous for risk allele; R/R, homozygous for non-risk allele</p>
###xml 2373 2715 2247 2587 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36">Data are means&#8201;&#177;&#8201;SD</p><p textid="37"><sup>a</sup>Multiple linear regression was carried out after logarithmic transformation for data not in normal distribution</p><p textid="38"><sup>b</sup>Adjusted for age and sex (BMI, waist and waist to hip ratio), or age, sex and log<sub><italic>e</italic></sub> BMI (all other traits)</p><p textid="39">C/C, homozygous for risk allele; C/R, heterozygous for risk allele; R/R, homozygous for non-risk allele</p></table-wrap-foot>
###xml 604 2715 604 2587 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="35">Effect of candidate SNP variant genotypes on clinical and biochemical variables in control individuals</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">SNP</th><th rowspan="2">Risk allele</th><th rowspan="2">Non-risk allele</th><th rowspan="2">Phenotypic characteristic<sup>a</sup></th><th colspan="3">Genotypes</th><th colspan="3"><italic>p</italic> value<sup>b</sup></th></tr><tr><th>C/C</th><th>C/R</th><th>R/R</th><th>Additive</th><th>Dominant</th><th>Recessive</th></tr></thead><tbody><tr><td rowspan="7">rs2237892</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.3&#8201;&#177;&#8201;3.13</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.30</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.42</td><td char="." align="char">0.039</td><td char="." align="char">0.483</td><td char="." align="char">0.020</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.9&#8201;&#177;&#8201;9.08</td><td char="&#177;" align="char">83.2&#8201;&#177;&#8201;8.79</td><td char="&#177;" align="char">84.9&#8201;&#177;&#8201;16.3</td><td char="." align="char">0.043</td><td char="." align="char">0.019</td><td char="." align="char">0.223</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.07</td><td char="." align="char">0.635</td><td char="." align="char">0.492</td><td char="." align="char">0.844</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.83&#8201;&#177;&#8201;0.60</td><td char="&#177;" align="char">4.75&#8201;&#177;&#8201;0.71</td><td char="." align="char">0.051</td><td char="." align="char">0.047</td><td char="." align="char">0.190</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.81&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.69</td><td char="." align="char">0.064</td><td char="." align="char">0.781</td><td char="." align="char">0.012</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.48&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.53&#8201;&#177;&#8201;0.80</td><td char="." align="char">0.517</td><td char="." align="char">0.583</td><td char="." align="char">0.221</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.64&#8201;&#177;&#8201;1.08</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.60&#8201;&#177;&#8201;0.85</td><td char="." align="char">0.404</td><td char="." align="char">0.978</td><td char="." align="char">0.255</td></tr><tr><td rowspan="7">rs2237895</td><td rowspan="7">C</td><td rowspan="7">A</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">23.9&#8201;&#177;&#8201;2.86</td><td char="&#177;" align="char">24.5&#8201;&#177;&#8201;3.34</td><td char="&#177;" align="char">24.6&#8201;&#177;&#8201;3.22</td><td char="." align="char">0.027</td><td char="." align="char">0.200</td><td char="." align="char">0.006</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.0&#8201;&#177;&#8201;8.47</td><td char="&#177;" align="char">83.0&#8201;&#177;&#8201;9.06</td><td char="&#177;" align="char">83.8&#8201;&#177;&#8201;11.1</td><td char="." align="char">0.012</td><td char="." align="char">0.036</td><td char="." align="char">0.048</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.05</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.093</td><td char="." align="char">0.058</td><td char="." align="char">0.655</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.69</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.62</td><td char="&#177;" align="char">4.81&#8201;&#177;&#8201;0.65</td><td char="." align="char">0.188</td><td char="." align="char">0.081</td><td char="." align="char">0.913</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.75&#8201;&#177;&#8201;0.57</td><td char="&#177;" align="char">5.78&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.79&#8201;&#177;&#8201;0.57</td><td char="." align="char">0.651</td><td char="." align="char">0.779</td><td char="." align="char">0.595</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.42&#8201;&#177;&#8201;0.84</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="&#177;" align="char">4.51&#8201;&#177;&#8201;0.88</td><td char="." align="char">0.748</td><td char="." align="char">0.811</td><td char="." align="char">0.245</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.59&#8201;&#177;&#8201;1.10</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.61&#8201;&#177;&#8201;1.09</td><td char="." align="char">0.986</td><td char="." align="char">0.831</td><td char="." align="char">0.733</td></tr><tr><td rowspan="7">rs2237897</td><td rowspan="7">C</td><td rowspan="7">T</td><td>BMI (kg/m<sup>2</sup>)</td><td char="&#177;" align="char">24.2&#8201;&#177;&#8201;3.15</td><td char="&#177;" align="char">24.7&#8201;&#177;&#8201;3.28</td><td char="&#177;" align="char">24.9&#8201;&#177;&#8201;3.36</td><td char="." align="char">0.002</td><td char="." align="char">0.074</td><td char="." align="char">0.002</td></tr><tr><td>Waist (cm)</td><td char="&#177;" align="char">82.7&#8201;&#177;&#8201;9.13</td><td char="&#177;" align="char">83.5&#8201;&#177;&#8201;8.80</td><td char="&#177;" align="char">84.6&#8201;&#177;&#8201;15.2</td><td char="." align="char">0.004</td><td char="." align="char">0.017</td><td char="." align="char">0.018</td></tr><tr><td>Waist to hip ratio</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="&#177;" align="char">0.86&#8201;&#177;&#8201;0.06</td><td char="." align="char">0.576</td><td char="." align="char">0.703</td><td char="." align="char">0.608</td></tr><tr><td>Fasting plasma glucose (mmol/l)</td><td char="&#177;" align="char">4.82&#8201;&#177;&#8201;0.66</td><td char="&#177;" align="char">4.85&#8201;&#177;&#8201;0.61</td><td char="&#177;" align="char">4.77&#8201;&#177;&#8201;0.68</td><td char="." align="char">0.562</td><td char="." align="char">0.155</td><td char="." align="char">0.854</td></tr><tr><td>HbA<sub>1c</sub> (%)</td><td char="&#177;" align="char">5.80&#8201;&#177;&#8201;0.55</td><td char="&#177;" align="char">5.76&#8201;&#177;&#8201;0.53</td><td char="&#177;" align="char">5.77&#8201;&#177;&#8201;0.66</td><td char="." align="char">0.133</td><td char="." align="char">0.662</td><td char="." align="char">0.047</td></tr><tr><td>Total cholesterol (mmol/l)</td><td char="&#177;" align="char">4.52&#8201;&#177;&#8201;0.90</td><td char="&#177;" align="char">4.47&#8201;&#177;&#8201;0.87</td><td char="&#177;" align="char">4.56&#8201;&#177;&#8201;0.83</td><td char="." align="char">0.630</td><td char="." align="char">0.368</td><td char="." align="char">0.193</td></tr><tr><td>Triacylglycerol (mmol/l)</td><td char="&#177;" align="char">1.63&#8201;&#177;&#8201;1.11</td><td char="&#177;" align="char">1.58&#8201;&#177;&#8201;1.03</td><td char="&#177;" align="char">1.67&#8201;&#177;&#8201;1.18</td><td char="." align="char">0.991</td><td char="." align="char">0.332</td><td char="." align="char">0.508</td></tr></tbody></table><table-wrap-foot><p textid="36">Data are means&#8201;&#177;&#8201;SD</p><p textid="37"><sup>a</sup>Multiple linear regression was carried out after logarithmic transformation for data not in normal distribution</p><p textid="38"><sup>b</sup>Adjusted for age and sex (BMI, waist and waist to hip ratio), or age, sex and log<sub><italic>e</italic></sub> BMI (all other traits)</p><p textid="39">C/C, homozygous for risk allele; C/R, heterozygous for risk allele; R/R, homozygous for non-risk allele</p></table-wrap-foot></table-wrap>
As treatment for diabetes may have affected metabolic relationships, only non-diabetic individuals were included in the metabolic traits analysis. We found all three variants were associated with BMI and waist measurement, with the homozygous carriers of diabetes-associated allele showing the lowest value. Under the recessive model, rs2237892 and rs2237897 were associated with HbA1c levels and rs2237892 also showed association with fasting plasma glucose levels under the additive model (Table 3). Apart from these associations, the variants were not associated with any other measures in our study. Table 3Effect of candidate SNP variant genotypes on clinical and biochemical variables in control individualsSNPRisk alleleNon-risk allelePhenotypic characteristicaGenotypesp valuebC/CC/RR/RAdditiveDominantRecessivers2237892CTBMI (kg/m2)24.3 +/- 3.1324.7 +/- 3.3024.7 +/- 3.420.0390.4830.020Waist (cm)82.9 +/- 9.0883.2 +/- 8.7984.9 +/- 16.30.0430.0190.223Waist to hip ratio0.86 +/- 0.060.86 +/- 0.070.86 +/- 0.070.6350.4920.844Fasting plasma glucose (mmol/l)4.85 +/- 0.664.83 +/- 0.604.75 +/- 0.710.0510.0470.190HbA1c (%)5.81 +/- 0.555.75 +/- 0.535.77 +/- 0.690.0640.7810.012Total cholesterol (mmol/l)4.52 +/- 0.904.48 +/- 0.884.53 +/- 0.800.5170.5830.221Triacylglycerol (mmol/l)1.64 +/- 1.081.58 +/- 1.101.60 +/- 0.850.4040.9780.255rs2237895CABMI (kg/m2)23.9 +/- 2.8624.5 +/- 3.3424.6 +/- 3.220.0270.2000.006Waist (cm)82.0 +/- 8.4783.0 +/- 9.0683.8 +/- 11.10.0120.0360.048Waist to hip ratio0.86 +/- 0.050.86 +/- 0.060.86 +/- 0.060.0930.0580.655Fasting plasma glucose (mmol/l)4.82 +/- 0.694.85 +/- 0.624.81 +/- 0.650.1880.0810.913HbA1c (%)5.75 +/- 0.575.78 +/- 0.555.79 +/- 0.570.6510.7790.595Total cholesterol (mmol/l)4.42 +/- 0.844.51 +/- 0.884.51 +/- 0.880.7480.8110.245Triacylglycerol (mmol/l)1.59 +/- 1.101.61 +/- 1.031.61 +/- 1.090.9860.8310.733rs2237897CTBMI (kg/m2)24.2 +/- 3.1524.7 +/- 3.2824.9 +/- 3.360.0020.0740.002Waist (cm)82.7 +/- 9.1383.5 +/- 8.8084.6 +/- 15.20.0040.0170.018Waist to hip ratio0.86 +/- 0.060.86 +/- 0.060.86 +/- 0.060.5760.7030.608Fasting plasma glucose (mmol/l)4.82 +/- 0.664.85 +/- 0.614.77 +/- 0.680.5620.1550.854HbA1c (%)5.80 +/- 0.555.76 +/- 0.535.77 +/- 0.660.1330.6620.047Total cholesterol (mmol/l)4.52 +/- 0.904.47 +/- 0.874.56 +/- 0.830.6300.3680.193Triacylglycerol (mmol/l)1.63 +/- 1.111.58 +/- 1.031.67 +/- 1.180.9910.3320.508Data are means +/- SDaMultiple linear regression was carried out after logarithmic transformation for data not in normal distributionbAdjusted for age and sex (BMI, waist and waist to hip ratio), or age, sex and loge BMI (all other traits)C/C, homozygous for risk allele; C/R, heterozygous for risk allele; R/R, homozygous for non-risk allele
###end p 34
###begin p 35
Effect of candidate SNP variant genotypes on clinical and biochemical variables in control individuals
###end p 35
###begin p 36
Data are means +/- SD
###end p 36
###begin p 37
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aMultiple linear regression was carried out after logarithmic transformation for data not in normal distribution
###end p 37
###begin p 38
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e</italic>
###xml 82 83 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>e</italic></sub>
bAdjusted for age and sex (BMI, waist and waist to hip ratio), or age, sex and loge BMI (all other traits)
###end p 38
###begin p 39
C/C, homozygous for risk allele; C/R, heterozygous for risk allele; R/R, homozygous for non-risk allele
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM4">4</xref>
We found the variants located at intron 15 of KCNQ1, rs2237892, rs2237895 and rs2237897, to be associated with type 2 diabetes. These results are consistent with previous studies [18-20]. The variant rs2237897 showed the strongest association with type 2 diabetes after testing for independent effects, which was consistent with the study of Tan et al. [20]. In addition, the conditional independent effects test of rs2237892, rs2237895 and rs2237897 confirmed that they were in a linkage disequilibrium block, as the effects of rs2237892 and rs2237895 on type 2 diabetes could be equally attributable to rs2237897 (see ESM Table 4).
###end p 41
###begin p 42
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 182 187 182 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kcnq1</italic>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 995 997 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 1032 1037 1032 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kcnq1</italic>
###xml 1146 1151 1146 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 1234 1236 1234 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 1452 1457 1452 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 1569 1571 1569 1571 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1c</sub>
###xml 1758 1760 1758 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 1948 1950 1948 1950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 2173 2178 2173 2178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 1043 1047 <span type="species:ncbi:10090">mice</span>
KCNQ1, which encompasses 404 kb, is located at chromosome 11p15.5, not far from a candidate region at 11p13-p12 that two independent studies have linked to type 2 diabetes [24, 25]. KCNQ1 encodes a pore-forming subunit of the voltage-dependent K+ ion channel, which is expressed mainly in the heart and, to a lesser extent, in the brain, adipose tissue and pancreas. The two most important roles of potassium voltage-gated channel, KQT-like (KCNQ1) channels are: (1) repolarisation of the cardiac tissue following an action potential; and (2) water and salt transport in epithelial tissues. Moreover, mutations in KCNQ1 can lead to dysfunction of the channel and cause the cardiac long QT syndrome LQTS1 that, in turn, may lead to serious arrhythmias, ventricular fibrillation and cardiac arrest. Kcnq1-knockout mice have been reported to show cardiac dysfunctions such as prolonged QT interval, hypochlorhydria, hypergastrinaemia, gastric hyperplasia and vacuolation of the parietal cells [26, 27]. For type 2 diabetes, homozygous Kcnq1-null mice have been reported not to show hyperglycaemia or glucose intolerance, and the contribution of the KCNQ1-encoded protein to the molecular pathogenesis of type 2 diabetes remains unclear [19]. We found that homozygous carriers of diabetes-associated allele showed the lowest BMI in the control group, which contradicted the theory that weight gain may increase the risk of diabetes. This suggests that the KCNQ1 gene may impact on the pathogenesis of diabetes through pathways other than weight gain. The association of HbA1c levels and fasting plasma glucose levels in our study, and the association of higher fasting glucose levels and reduced corrected insulin response at 120 min in the study of Tan et al. [20], in conjunction with the lower homeostasis model assessment for beta cell function or corrected insulin response apparent for C-C homozygotes of rs2237892 in the study of Yasuda et al. [18], may reflect a functional role for this channel in beta cell function and the pathogenesis of type 2 diabetes. Thus, further studies will be useful to replicate these promising findings and to fully delineate the role of KCNQ1.
###end p 42
###begin p 43
###xml 453 458 453 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
###xml 545 551 <span type="species:ncbi:9606">people</span>
In the present study, the distribution of haplotypes constructed by rs2237892, rs2237895 and rs2237897 showed significant differences between cases and controls, particularly the C-C-C haplotype and the T-A-T haplotype. Thus, it can be seen that the three variants are in an LD block. However, no variant in this region has been detected to have a direct function, so we suggest that there may be one or more other functional variants in this region of KCNQ1. In a recent study, large gene deletions and duplications in KCNQ1 were identified in people with long QT syndrome [28]. This suggests that copy-number variants in KCNQ1 also play a role in associated complex diseases. To clarify the role of KCNQ1 in susceptibility to type 2 diabetes, further research is needed into the SNPs and copy-number variants.
###end p 43
###begin p 44
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="MOESM5">5</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
In addition, compared with the controls in previous studies (see ESM Table 5), the minor allele frequencies of all three variants in our population from mainland China were higher or lower than in other populations; for example, the frequency of SNP rs2237897 in our Chinese sample was close to that in the Singapore Chinese population, higher than that in the Japanese population and completely different from the frequency in the Danish population (63.8%, 65%, 61% and 96%, respectively) [18-20]. These results confirmed the differences in frequencies of some genetic variations among different ethnic groups and different geographic regions. At the same time, these differences also highlight the need to extend genome-wide association scans and subsequent replication studies to different populations.
###end p 44
###begin p 45
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
In summary, we detected the association of KCNQ1 with type 2 diabetes and some diabetes-related traits in the population of mainland China. In addition, the haplotype distribution was found to be significantly different between cases and controls. These findings may be useful in further research into the pathogenesis of type 2 diabetes, as well as in advancing clinical practice and public health genomics.
###end p 45
###begin title 46
Electronic supplementary material
###end title 46
###begin p 47
Below is the link to the electronic supplementary material.
###end p 47
###begin p 48
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
Genetic mode selection test for variants of KCNQ1 (PDF 31 kb)
###end p 48
###begin p 49
###xml 17 19 17 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D&#8242;</italic>
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
LD coefficients (D' and r2) among SNPs in KCNQ1 (PDF 26 kb)
###end p 49
###begin p 50
Estimated haplotype frequencies and association significance (PDF 51 kb)
###end p 50
###begin p 51
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
Tests of the independent effect of each SNP in KCNQ1 (PDF 26 kb)
###end p 51
###begin p 52
Genetic differences among different control populations (PDF 8 kb)
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
We thank the individuals who participated in the present study. This work was supported by grants from the National Key Technology R&D Program (2006BAI05A05), S973 Program (2007CB947300), 863 Program (2006AA02A407), S973 Program (2006CB910601), the Opening Project of Shanghai Key Laboratory of Complex Prescription (07DZ22917), the Shanghai-Unilever Research and Development Fund (06SU07007), the Shanghai Leading Academic Discipline Project (B205), the Chinese Nutrition Society (05015), the Shanghai Municipality Science & Technology Commission (05JC14090) and the Chinese Academy of Sciences (KSCX2-YW-R-01).
###end p 54
###begin p 55
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Duality of interest statement</bold>
Duality of interest statement The authors declare that there is no duality of interest associated with this manuscript.
###end p 55
###begin p 56
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 56
###begin title 57
References
###end title 57
###begin article-title 58
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
###end article-title 58
###begin article-title 59
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
###end article-title 59
###begin article-title 60
Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes
###end article-title 60
###begin article-title 61
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
###end article-title 61
###begin article-title 62
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes
###end article-title 62
###begin article-title 63
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
###end article-title 63
###begin article-title 64
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
###end article-title 64
###begin article-title 65
A genome-wide association study identifies novel risk loci for type 2 diabetes
###end article-title 65
###begin article-title 66
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
###end article-title 66
###begin article-title 67
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
###end article-title 67
###begin article-title 68
Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population
###end article-title 68
###begin article-title 69
Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6, 719 Asians
###end article-title 69
###begin article-title 70
Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population
###end article-title 70
###begin article-title 71
Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761 and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians
###end article-title 71
###begin article-title 72
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 129 141 <span type="species:ncbi:9606">participants</span>
Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study)
###end article-title 72
###begin article-title 73
Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals
###end article-title 73
###begin article-title 74
Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value
###end article-title 74
###begin article-title 75
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
###end article-title 75
###begin article-title 76
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations
###end article-title 76
###begin article-title 77
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNQ1</italic>
Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: a study of 3734 subjects comprising three ethnicities living in Singapore
###end article-title 77
###begin article-title 78
Positive association between OLIG2 and schizophrenia in the Chinese Han population
###end article-title 78
###begin article-title 79
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
###end article-title 79
###begin article-title 80
Estimating the population attributable risk for multiple risk factors using case-control data
###end article-title 80
###begin article-title 81
Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13-p12 in Japanese
###end article-title 81
###begin article-title 82
Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate loci on 7p and 11p
###end article-title 82
###begin article-title 83
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice
###end article-title 83
###begin article-title 84
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome
###end article-title 84
###begin article-title 85
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome
###end article-title 85
###begin title 86
Abbreviations
###end title 86
###begin p 87
Linkage disequilibrium
###end p 87
###begin p 88
Population attributable risk
###end p 88
###begin p 89
Single nucleotide polymorphism
###end p 89
###begin p 90
Y. Liu and D. Z. Zhou contributed equally to this study.
###end p 90
###begin p 91
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 91
###begin p 92
The online version of this article (doi:10.1007/s00125-009-1375-y) contains supplementary material, which is available to authorised users.
###end p 92

